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ABSTRACT
Influenza A virus Reassortment and Genome Packaging
by
Graham D. Williams
Doctor of Philosophy in Biology and Biomedical Sciences
Molecular Microbiology and Microbial Pathogenesis
Washington University in St. Louis, 2017
Professor Adrianus Boon, Chair
Influenza A viruses (IAV) are a major human and environmental pathogen. IAV
successfully infects a diverse host range and adaptation of new viral strains to humans may cause
pandemic events with high morbidity and mortality. As a member of the Orthomyxoviridae
family, IAV inherently possesses a segmented genome, which enables a process of segment
transmission between viruses following cellular co-infection, a process termed reassortment. The
high rate of IAV mutation and continued co-circulation of diverse viral strains in divergent host
species leads to the persistent prospect for emergence of new IAV with pandemic potential.
Therefore, it is of great importance to understand the viral and host factors that restrict and
promote the generation of emergent virus strains, their potential for pathogenesis, and discover
novel mechanistic countermeasures against IAV, including improved vaccination and targeted
therapeutic strategies.
Human and avian IAV co-circulate and occasionally co-infect the same host, leading to
the potential for generation of novel genome constellations following reassortment. The specific
host and viral molecular determinants that allow replication of reassortant progeny virus are not
well defined. Here, I show that the viral genetic context and host cell in which reassortment
occurs determine the potential for genetic diversity derived from multiple distantly related
strains. Importantly, we identify single gene reassortants between a North American avian strain
and the 2009 pandemic H1N1 virus that are capable of causing disease in mammals and replicate
in a human cell line as well as induce the production of several pro-inflammatory cytokines
linked to severe disease outcomes. Additionally, utilizing a different viral genetic background, I
show that the reassortment potential is regulated by species and cell type specific differences in
viii

viral replication due to augmented viral polymerase function dependent on the identity of a
single amino acid in the PA protein. Together, these studies provide evidence that contextdependent compatibility between both viral and host factors determine the possibility for
generation of novel reassortant genome constellations and regulate their potential for replication
and transmission in new host species.
Reassortment between IAV strains is likely dictated by the functional compatibility of
vRNA segments bound by IAV nucleoprotein during genome packaging. I hypothesized that
nucleoprotein (NP) scaffolds specific RNA elements that are required for genome packaging and
interaction between viral RNA (vRNA) genome segments. Therefore, I sought to determine the
functional consequences of genome architecture on genome packaging and for the first time
determine the nucleotide-resolution landscape of NP-vRNA interactions in infected cells. We
utilized Photoactivatable Ribonucleoside-Enhanced Crosslinking and Immunoprecipitation
(PAR-CLIP) coupled to next-generation sequencing to determine the specific interaction sites of
vRNA bound by NP. We then interrogated the functional importance of regions of vRNA bound
or unbound by NP and identified a number of potentially structured RNA features required for
efficient genome packaging and virus propagation. These studies provide a framework for
understanding the multifactorial restrictions of IAV reassortment and potential for generation of
novel genome constellations with pandemic potential. Finally, these studies expand our
understanding of how viral and host determinants shape the possible evolutionary trajectories of
IAV through reassortment and required genetic elements needed for genome assembly.
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CHAPTER 1:
INTRODUCTION

1

1.1

Influenza A virus as a Cause of Human and Animal Disease
Influenzavirus A viruses are part of the Orthomyxoviridae family that also consists of related

but distinct members including Influenzavirus B, Influenzavirus C, Thogotovirus, and Isavirus1.
While Influenza A, B, and C genera and Thogotoviruses infect humans and a wide variety of
other organisms, Isaviruses are presently understood as restricted to aquatic vertebrates.
Influenza A (IAV) and B (IBV) viruses pose the greatest risk to humans. IAV can infect a highly
divergent cohort of birds, humans, domestic pigs, horses, dogs, and aquatic mammals but
influenza B virus is restricted to humans.
Influenza infection in humans is generally limited to the respiratory epithelium, although
dissemination to other organs has been observed in some highly pathogenic strains2,3.
Transmission of the virus occurs by respiratory droplet as well as contact with contaminated
surfaces. High population density (i.e. schools or workplaces) and direct exposure to infected
individuals leads to increased transmission of the disease4. As a respiratory pathogen, the
mucosal epithelial surface and innate immune system play large roles in host protection5. In dry
air, mucous in the airway is thinned and leads to greater likelihood of infection6. Influenza
pathogenesis is mediated by immune infiltration and inflammation in the airway as well as
enhanced inflammatory cytokine release leading to edema at the sites of infection and
replication7. Symptoms consist of coughing, fever, rhinitis, and malaise occurring within 2 days
of exposure that general resolve within 7-10 days. Viral shedding and contagiousness may occur
before the onset of symptoms making disease control and spread a large public health issue.
1.2

Influenza A Ecology and Zoonosis
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IAV is a genetically diverse viral species, presently including 17 HA subtypes and 10 NA
subtypes, classified by both differential immune recognition and sequence composition8. H1N1,
H3N2, and H2N2 subtypes have circulated widely in the human population, while other subtypes
are largely restricted to other mammals or the natural reservoir of migratory and shore birds9.
Avian IAV including subtypes H5, H7, and H9 cause sporadic, sometimes fatal disease in
humans and are major agricultural pathogens10. Zoonosis of these viruses or derivative lineages
formed by reassortment with human transmissible strains may lead to the emergence of viruses
with pandemic potential11–13. Therefore, it is of great importance to determine the molecular basis
of replication and pathogenesis of contemporary avian viruses in the mammalian host. IAV’s
containing subtype H7 Hemagglutanin may pose the greatest threat to human health beyond
seasonal influenzas of subtypes H1 and H314. In the past decade there have been multiple
outbreaks of H7N1, H7N3, and most recent H7N9 viruses in avian and human populations15–17.
These outbreaks are geographically distinct and are not the result of movement of viruses across
geographic regions.
Encounters with H7 viruses are likely common in human populations, though substantial
adaptation may have to occur before they can cause fulminant respiratory disease.
Seroprevalence studies in Italy, China, and North America reveal the presence of antibodies to
H7 (at least H7 cross-reactive) antibodies in many people18. Additional human cases in North
America have been documented. A small 2004 outbreak in British Columbia resulted in the
infection of two poultry workers19.
In addition to these low-pathogenic strains (LPAIs), the H7 subtype may harbor a multibasic cleavage site (MBCS) found in highly-pathogenic strains (HPAIs)20. Interestingly, these
strains are able to acquire this cleavage signal likely through recombination with host rRNA.
3

During 2012-2013 a highly pathogenic H7N3 strain in Mexico acquired an MBCS through
inclusion of a 11 amino acid sequence immediately proximal to the H0-H1 cleavage site. The
resulting virus is more pathogenic in Galliformes and can cause disease in mammals as
evidenced by multiple infections as a result of occupational exposure.
North American H7 viruses isolated from aquatic birds have receptor binding affinity to
human-like sialic acids 19. Additionally, most humans are not seroreactive to H7-HA and this
population-level naivety, and lack of neutralizing antibodies, may allow rapid spread of a greater
outbreak than potentially a moderately, antigenically distinct H1 or H3. Both H7- and H1subtype viruses are capable of infecting mammalian hosts. As both H7 and H1 subtype viruses
co-circulate geographically, there is the possibility that reassortment a process described below,
between the viruses may result in a strain with altered properties11.
1.3

Genome Reassortment Produces Pandemic Influenza Viruses
IAV possess a genome composed of eight single-stranded negative-sense RNA segments

encapsulated in a nucleoprotein coat and polymerase complex packaged in a host-cell derived
envelope21. In the event of cellular coinfection, viral ribonucleoprotein complexes (vRNPs) from
multiple strains of the virus are able to simultaneously utilize the host cell for replication and
genome packaging. If a mixed genome is successfully packaged, resulting viruses with segments
from both parental strains result - giving rise to a new genome constellation9. This process,
termed reassortment, is one of the evolutionary strategies employed by IAV to produce new viral
strains that may have altered replication, pathogenesis, and transmission profiles when compared
to previous isolates. For reassortment to be successful new genomic constellations must be
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replication competent and when there is little difference between constituent segments of two
viruses reassortment may occur at a high frequency.
Influenza reassortment has led to the generation of multiple viruses capable of generating
pandemics22–25. Requisite for pandemic formation is the ability of the virus to break animal-tohuman transmission barriers, replicate and release efficiently in the human host, and transmit
form human-to-human26. The profound effect of reassortment may be illustrated by inspecting
the phylogeny of pandemic IAVs from 1918 to 2009 and the recently emergent H7N927,28. In
each case an antigenically distinct HA was acquired by way of reassortment with a virus capable
of transmitting to and replicating in humans29,30. Humoral immunity to HA is the primary basis of
current vaccination strategies and antigenic shift of HA by reassortment alters recognition by
antibodies. The 1918 H1N1 "Spanish Flu" was likely created by reassortment of at least one
avian virus and a mammalian virus that circulated in porcine hosts before introduction to
humans31,32. Between 20-50 million people died as a result of primary influenza infection and
subsequent secondary pneumonia. Contemporary segments with high homology to the 1918
H1N1 strain persist in both avian and swine populations27. Experimental creation of an H1N1
strain derived from currently circulating avian genome segments was also shown to cause severe
disease in mammals and can transmit between ferrets. Moreover, reassortment between human
and avian IAV, likely in a porcine vessel, resulted in the generation of H2N2 and H3N2 strains
that caused pandemics in 1957 and 1968, respectively. H3N2 viruses have continued to circulate
following the pandemic and are, along with H1N1, the primary cause of seasonal epidemics.
Prior to each pandemic, antigenic shift of HA or NA occurred in addition to transfer of
internal gene segments. The 2009 pandemic H1N1 emerged following at least three independent
reassortment events involving human, porcine, and avian viruses32. The compatibility of genome
5

segments from this virus with both high and low pathogenic contemporary avian influenza
viruses in experimental settings is concerning. Mammal-to-mammal transmission of non-adapted
single gene reassortants has been experimentally demonstrated4,11,13,33,34. Reassortment of IAV
viruses occurs readily in nature and may be simulated in the lab using either co-infection or
forced reverse genetic approaches.
Many recent studies have assessed the effect of reassortment between 2009 pandemic
H1N1 and other virus strains. In many cases reassortment resulted in increased pathogenesis of
porcine viruses. Additionally, many cases of reassortment between 2009 pandemic H1N1 and
endemic porcine viruses have been documented. Paired with the potential for reassortment with
wild aquatic birds, shorebirds and mallards included, investigation of the potential for
reassortment and altered pathogenesis in LPAI H7 viruses with the 2009 pandemic H1N1 virus
are imperative. For instance, does the acquisition of structural or non-structural genes from
human viruses lead to increased replication, pathogenesis, or transmission of environmentally
obtained North American avian influenza viruses? This question will be partially addressed by
Chapter 2 of this thesis.
1.4

IAV Genome Structure and Virally Encoded Proteins
Upon infection of the host cell, negative-sense genome segments are trafficked to the

nucleus and generate a positive-sense RNA intermediate that acts as a template for genome
replication and may be enzymatically modified to serve as message for translation of viral
proteins35. Influenza viruses possess an RNA-dependent RNA Polymerase (RdRP) complex that
also facilitates an endonucleolytic cap-snatching mechanism for co-opting the host
transcriptional machinery to produce viral proteins.36 Individual IAV particles are thought to
6

contain one copy of each of the eight genomic segments37,38. The proportion of infectious to
defective particles created during infection remains controversial, potentially a consequence of
inefficient genome packaging39. Encoded by these eight segments are at least 12 functionally
distinct proteins: PB2, PB1, PB1-F2, PA, PA-X, HA, NP, NA, M1, M2, NS1, and NEP (NS2)
(Table 1.1)1. PB2, PB1, and PA along with NP compose the viral replication machinery. HA and
NA are surface glycoproteins associated with host cell attachment and budding respectively34.
The nonstructural proteins NS1 and NEP act, respectively, as regulators of the host immune
response and in export of vRNPs from the nucleus40,41. All of these proteins intimately interact
with host cellular components during the course of entry, endosomal fusion, replication, and
budding leading to dissemination of the virus and pathogenic features of infection (Figure 1.1)42.

7

Segment
(length, nt)

Protein

Primary Function

1 (2341)

PB2

Cap-binding domain of RdRP*

2 (2341)

PB1

Catalytic subunit of RdRP

PB1-F2

Pro-apoptotic, immune modulatory

PA

Cap-snatching endonuclease in RdRP

PA-X

Host cell shut-off, “non-specific” endonuclease,
immune modulation

4 (1775)

HA

Surface glycoprotein,
membrane fusion

5 (1565)

NP

Nucleoprotein, encapsidation of viral RNAs

6 (1413)

NA

Surface glycoprotein, Neuraminidase activity,
receptor destruction and particle egress from host
cell

7 (1027)

M1

Matrix protein, particle morphology, vRNP export

M2

Surface cation channel, protects HA conformation

NS1

Regulation of RdRP, Interferon antagonist,
enhancement of viral mRNA translation

NEP (NS2)

Nuclear export factor

3 (2233)

8 (890)

host

cell

attachment,

Table 1.1. Proteins encoded by each IAV segment and ascribed functions.
*RdRP: RNA-dependent RNA polymerase
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1.5 IAV Receptor Binding, Entry, Endosomal Fusion and Uncoating
IAV has a class I fusion protein, Hemagglutinin (HA), that adorns the viral envelope43.
HA binds sialic acid moieties on the host cell surface and is internalized by a variety of
pathways44,45. Spherical viruses generally enter through clathrin-dependent, receptor-mediated
endocytosis of the virus followed by passage through the endocytic pathway concluding with
fusion in the late endosome at low-pH46. Filamentous influenza A viruses enter the cell via a
clathrin-independent, dynamin-independent pathway44,47. HA induces membrane fusion between
viral and host membrane and M2 activation occurs and viral acidification induces separation of
M1 and vRNPs allowing their export to the cytoplasm and subsequently the nucleus48.
1.6 vRNP transport to the Host Cell Nucleus
Following fusion and uncoating, vRNPs must traverse the cytoplasm prior to nuclear
entry49. In the cytoplasm vRNPs are individually bound by importin-alpha proteins that
recognized nuclear localization signals within viral proteins. After importin-alpha loading, an
active transport process involving host Ran-GTPases allows traversal of the nuclear pore
complex50. The recognition by importin-alpha likely relies on a non-classical NLS in the solvent
exposed N-terminus of NP present at high copy number within vRNPs35. Additionally, PB2 is
known to interact with host importins as well, though at only one copy per vRNP, the
contribution of these interactions to nuclear import remain unclear.

9

Figure 1.1. Schematic of the influenza A virus infection cycle. Adapted from Shi, et al.
Nature Reviews Microbiology. 20131. IAV particles bind host-derived sialic acids via HA and
induce virus uptake at the cell membrane. IAV is trafficked to the late endosome prior to pHdependent HA fusion in the endolysosome. Particle uncoating occurs as M2 is activated and M1
detaches from vRNPs, allowing their export to the host cytoplasm. vRNPs are transported to the
nucleus via host proteins and cross the nuclear pore complex and pioneer transcription and
protein production proceed. Following accumulation of proteins involved in genome replication,
a positive-sense replication intermediate (cRNP) is generated from vRNA template, and then
transcription of nascent vRNPs proceeds and amplifies viral RNA content in the nucleus. vRNPs
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are actively transported from the nucleus to the cytoplasm where they assemble as multisegmented foci at Rab11a-positive vesicles and are trafficked en masse to the interior of the
plasma membrane at sites of viral budding. Progeny virus bud from the cell membrane and via
M2-dependent scission thereby enabling release from the cell.
1.7 Viral Protein synthesis, Cap-snatching, and Genome Replication
Following nuclear import, the initial round of primary transcription from vRNA to viral
mRNA must occur. Primary transcription is initiated by trans-acting vRNPs to facilitate (+)strand synthesis aided by many cellular factors including RNA polymerase II51. For viral mRNA
to be produced and translated, a host-derived 5’leader sequence must be appended to the end of
(+)-strand viral RNA. This process, termed cap-snatching, occurs via the endonucleitic cleavage
of host mRNAs, via PA, following cap recognition by PB2 in the context of the heterotrimeric
polymerase complex36. The first 10-15 nucleotides of host RNA are appended to the viral RNA
and used as a template for translation following export from the nucleus52. A 3’-poly-A tail is
added by the host protein SFPQ and splicing of certain viral mRNAs occurs53. In the case of viral
transcripts lacking splice variants, these molecules are transported via the canonical host export
pathways including NXF154. For transcripts that possess retained introns (M1 and NS1), NS1
protein is required for efficient export due to occlusion of binding by host transcript quality
control proteins and the proofreading machinery54,55. Once exported the host ribosome translates
viral proteins. Each newly synthesized polymerase complex component must then be imported to
the nucleus for continued replication41. Multiple host factors function in concert with the viral
polymerase complex to transcribe and replication genomes56,57. After buildup of viral proteins,
cRNA production begins and continues processively with the help of the cellular
minichromosome maintenance complex, a helicase and clamp complex which allows extended
11

unwinding and synthesis along full-length transcripts58. Once unmodified cRNA is generated, it
is used as a copy-back template to synthesize vRNA to be packaged into progeny virions. In both
cases the synthesis of cRNA and vRNA likely occurs via RNP non-resident polymerase
complexes59. As RNA synthesis via the heterotrimeric polymerase component, PB1 proceeds
rapidly, it is possible nearly co-transcriptional coating of vRNA by NP may occur35. As NP
oligomerization along vRNA may happen slower than synthesis, local RNA structures may form.
These structures may facilitate potential inter-segment interactions to be discussed later in this
text.
1.8 vRNP Export and Transit to Budding Virion
Following vRNP synthesis, genome segments must be actively exported from the nucleus
to the sites of virus particle assembly. M1 participates in the transport of viral RNPs (vRNPs)
across the nuclear compartment by bridging the vRNP and NEP (NS2)40,60,61. This export process
is CRM1 and nuclear pore dependent. Following export of the CRM1-NEP-M1-vRNP complex
from the nucleus, PB2 in the vRNP associates with a virus-induced Rab11a-positive vesicle41,62,63.
Docking of vRNPs at this structure has shown to be dependent on vRNP-associated PB2 binding
host Rab11a. At this point, or before, higher order clusters of vRNPs form in the cytoplasm64.
The basis for molecular clustering remains undetermined but this portion of genome assembly
provides a platform for competition between genome segments65. As subgenomic packets of
vRNPs can be found directly following nuclear export, it seems likely that once vRNPs are
loaded onto these transport vesicles via PB2, the local concentration of vRNPs is great enough
for assembly of higher order, complete genomes. These interactions may occur via vRNA-vRNA
interactions, in trans, between vRNPs and be potentiated by proximity66–68.
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1.9 Influenza A Genome Segment and RNP Architecture
Each vRNA genome segment contains at least one open reading frame (ORF), and two
distal untranslated regions69–72. The 5’ and 3’ UTR, along with an overlapping portion of the ORF
are responsible for packaging of the segment into progeny viruses. Segment termini all contain a
universal 12 and 13 nucleotides, 5’ and 3’ respectively, that are nearly complementary and form
a corkscrew-like promoter implicated in priming of cRNA and vRNA synthesis by the
polymerase complex composed of PB2, PB1, and PA49,73,74.
IAV RNP complexes are comprised of the heterotrimeric polymerase complex as well as
viral nucleoprotein and RNA. Using a number of methods, including mass-spectrometry and
cryo-electron microscopy (EM), nucleoprotein has been hypothesized to bind approximately 2432 bases per monomer by calculating the number of NP monomers per polymerase in purified
virus or by dividing the length of a segment by the number of NP molecules present59,69,75,76.
Conversely, NP spontaneously assembles into vRNP-like helical structures in the presence of 1113 nucleotides, and this discrepancy has not been fully reconciled77. Modeling of NP-RNA
interactions additionally predicts the phosphate backbone of a 12 nucleotide model RNA may be
accommodates in the positively charged RNA-binding groove of monomeric NP78.
Reconstruction of vRNPs via cryo-EM describe these macromolecules as extended helical
structures in which the opposing termini of each segment are coordinated by the polymerase
complex. Nucleoprotein coils through interactions of a dimer interface along the segment length
save for a structurally required loop in the segment end distal to the polymerase complex. NP
binds to the phosphate backbone of vRNA in a manner that leaves bases exposed to solvent and
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potentially able to form RNA structures in the context of the vRNP, suggesting NP coating of
vRNA may be incomplete72,79. The structural approaches utilized to date have not quantified the
specific nucleotide interactions of vRNA with NP in the context of infected cells or purified
virus since the resolution limit of prior studies was not great enough to assign nucleotide
identities to vRNA density in class-averaged cryo-EM structures59,69. Additionally, single particle
cryo-EM studies demonstrate the potential for non-uniform helical torsion within vRNPs that
generates heterogeneous structural topology71. Therefore, nucleotide resolution analysis of the
NP-RNA interaction may elucidate previously unappreciated vRNP features required in IAV
biology.
1.10

Influenza A RNA Features Required for Coordinated Genome Packaging
Segment specific packaging signals have been identified for each segment utilizing

A/PR/08/1934 (H1N1) and A/WSN/1933 (H1N1) strains80–84. A/PR/08/1934 is the same strain of
virus we have used in many studies and is also used as one of the genomic backgrounds for
human vaccine development. Initial studies focused on internal truncations of large segments,
primarily the polymerase coding segments that are able to compete with wild type segments for
incorporation into the genome; these truncated segments have since been termed “Defective
Interfering RNAs” (DI RNA)85. Importantly, these truncated segments were shown to act at the
level of packaging, as they are able to compete with wild-type segments for incorporation into
progeny viruses and result in replication incompetent virus. Additionally, though many reverse
genetic experiments have examined the minimum requirements for DI-like RNA incorporation,
most have found the inclusion of terminal coding regions in addition to conserved untranslated
regions (UTR) confers a greater rate of incorporation relative to wild-type segments86. Similarly,
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the inclusion of terminal coding regions promoted more efficient packaging than the UTR alone.
More recently, reverse genetic studies employing artificial reporter segments have yielded
valuable information about the minimal requirements for efficient packaging. All segments have
demonstrated a requirement for a bipartite packaging signal derived from both segment termini87.
Interestingly, in many cases truncation of one segment leads to a significant decrease in the
packaging efficiency of other segments when measured on a segment-specific basis88. These
results suggest the segments may function as a multipartite, cooperatively packaged entity rather
than alone. This finding implies a bundling mechanism within the genome potentiated by
segment- segment interactions.
Information regarding structural features within the packaging signals and across entire
segments is lacking and may provide insights into how such seemingly minute changes in
sequence may have dramatic effects on replicative capacity89. Exposed vRNA may fold into
conserved structures allowing between-segment interactions90. Indeed vRNA is moderately
susceptible to RNase cleavage despite RNP formation, suggesting at minimum dynamic proteinRNA interactions and potentially highly exposed, short RNA structures89. In support of this
hypothesis complementary oligos targeting packaging regions are able to disrupt genome
packaging and inhibit viral replication. Complex RNA structures may form within IAV vRNPs
following co-transcriptional coating of RNA by nucleoprotein84. Consequently, the genome
structure of IAV may be attributed to interactions between segments or an undiscovered RNAbinding protein that is able to oligomerize genome segments following export from the nucleus.
One hypothesis suggests that the packaging signals may contain the bundling and recognition
motifs themselves. In this case RNA-RNA interactions between segments would be required for
efficient packaging and accounting within a newly forming genome. Electron micrographs of
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both IAV and Influenza B virus depict large regions of electron density that appear to extend
between genome segments37. More recently, studies have implicated non-canonical packaging
elements as critical for determining the relative selection rates of competing genome segments.
Additional studies show a single-interaction network between in vitro transcribed vRNAs66,67,90.
Interestingly, the interactions identified by this method differ by viral strain68. Further
experiments have established that genome packaging is dependent on the genome constellation
present at the time of packaging91,33,92,93. Experimental coinfection in vitro or by classical
reassortment following coinfection and antibody selection, has demonstrated co-segregation of
genome segments. For instance, during vaccine creation the seasonal NA and PB1 are found
together at high frequency93. Most importantly, the description of vRNA interactions within this
reports lie outside of the canonical packaging signals necessary for efficient incorporation of
reporter genomic segments94. These studies and our preliminary data described above provide the
basis for the following hypothesis: Interactions within and between vRNA segments drive
packaging in a competitive context and therefore likely contribute greatly to the potential for
reassortment during coinfection.
1.11

Exploring viral and host determinants of reassortment potential
The generation and continued replication of genetically diverse IAV in a wide range of

host species presents and ongoing challenge for human and animal health10,26,95,96. Within the
following chapters, three independent but interconnected studies describing in part the genetic
features of IAV that enable, as well as restrict, viral propagation and the rise of new IAV strains
are described. In chapter 2, I present a study on the potential for reassortment of a recent North
American avian H7N3 isolate with a panel of human and avian virus strains91. The consequences
of single-gene reassortment on viral replication pathogenesis in a mammalian model are
16

discussed. Subsequently, in chapter 3, studies examining the reassortment potential of a H1N1
isolate demonstrate that the genetic context in which a gene segment resides may determine the
fitness of a newly derived reassortant virus. In chapter 4, the interaction landscape of IAV NP
and the viral genome are exported at nucleotide resolution. We find that the NP RNA scaffold
likely allows formation of defined and required RNA structures that enable coordinated genome
packaging. Finally, in chapter 5, the implications of our findings and recommendations for
potential future studies are discussed in depth.
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Chapter 2:
A North American H7N3 influenza virus
supports reassortment with 2009 pandemic
H1N1 and induces disease in mice without
prior adaptation

This chapter was published in full as a research article in the Journal of Virology, a Journal of
the American Society of Microbiology on 2 March 2016.
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2.1 Abstract
Reassortment between H5 or H9 subtype avian and mammalian influenza A viruses
(IAV) can generate a novel virus that causes disease and transmits between mammals. This
information is currently not available for H7 subtype viruses. We evaluated the ability of a low
pathogenic North American avian H7N3 virus (A/shorebird/Delaware/22/2006) to reassort with
mammalian or avian viruses using a plasmid-based competition assay. In addition to genome
segments derived from an avian H7N9 virus, the H7N3 virus reassorted efficiently with the PB2,
NA and M segments from the 2009 pandemic H1N1 (PH1N1) virus. In vitro and in vivo
evaluation of the H7N3:PH1N1 7+1 reassortant viruses revealed that the PB2, NA, or M
segments from PH1N1 largely do not attenuate the H7N3 virus, whereas the PB1, PA, NP, or NS
genome segments from

P

H1N1 do. Additionally, we assessed the functionality of the

H7N3:PH1N1 7+1 reassortant viruses by measuring the inflammatory response in vivo. We
found that infection with wild-type H7N3 resulted in increased inflammatory cytokine
production relative to the PH1N1, which was further exacerbated by substitution of PH1N1 PB2
but not NA or M. Finally, we assessed if any adaptations occurred in the individually substituted
segments after in vivo inoculation and found no mutations suggesting PH1N1 PB2, NA, and M
are genetically stable in background of this H7N3 virus. Taken together, we demonstrate that a
North American avian H7N3 IAV is genetically and functionally compatible with multiple gene
segments from the 2009 pandemic influenza virus strain without prior adaptation.
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2.2 Importance
The 2009 pandemic H1N1 continues to circulate and reassort with other influenza viruses
creating novel viruses with increased replication and transmission potential in humans. Previous
studies have found that this virus can also reassort with H5N1 and H9N2 avian influenza viruses.
We now show that several genome segments of the 2009 H1N1 virus are also highly compatible
with a low pathogenic avian H7N3 virus and that these reassortant viruses are stable and not
attenuated in an animal model. These results highlight the potential for reassortment of H1N1
viruses with avian influenza virus and emphasize the need for continued surveillance of
influenza viruses in areas of co-circulation between avian, human and swine viruses.
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2.3 Introduction
Reassortment of influenza A viruses (IAV) produces diversity and antigenic novelty
within circulating strains, sometimes leading to the emergence of pandemic viruses that cause
widespread disease in humans. Avian IAV subtypes, including H5, H7, and H9, have caused
sporadic but sometimes fatal disease in humans

1,2

. Zoonosis of these viruses or derivative

lineages formed via reassortment with strains capable of human-to-human transmission may lead
to the emergence of novel viruses with pandemic potential 3. Indeed multiple avian-origin
viruses, most notably H5N1 and H9N2 strains were able to cause disease in mammals and had
limited, but enhanced transmission potential following experimental reassortment with the 2009
pandemic H1N1 (PH1N1)

2,4

. Genetically diverse IAV may therefore gain the ability to induce

disease and transmit between mammals if an appropriate genetic constellation is assembled
through reassortment.
H7-subtype viruses intermittently infect and cause disease in humans following contact
with infected birds

1,5

. Outbreaks of H7 viruses in humans have occurred in geographically

distinct areas including The Netherlands (2003), Canada (2004), Mexico (2012), and China
(2013) 6. Sporadic infections such as these, that sometimes result in severe disease, suggests that
introduction of a H7-subtype virus capable of sustained transmission between humans has the
potential to initiate a significant outbreak. Recently, a reassortant, low pathogenic H7N9 virus
emerged in China with a case-fatality rate of approximately 25%, making this the most severe
and sustained incursion of H7-subtype viruses into the human population 7. Although person-toperson transmission has not been consistently demonstrated, the virus is capable of limited
transmission in guinea pig and ferret models without prior adaptation, suggesting the potential
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acquisition of transmission-related adaptations through mutation or reassortment

7–10

. The

sustained and ongoing geographic co-circulation of H7-bearing viruses with the PH1N1 poses a
risk for reassortment that may create H7-bearing viruses containing one or more PH1N1-origin
gene segments 11.
Reassortment of IAV genes, including those endemic in animal reservoirs has given rise
to pandemic IAVs, most recently PH1N1 in 2009 12. In each case, antigenic shift of external
proteins occurred as well as transfer of gene segments encoding internal and nonstructural
proteins. PH1N1 resulted from three independent reassortment events involving genes from
swine, human, and avian viruses. This triple reassortant swine-origin IAV, first identified in
Mexico, consists of PB2, PB1, PA, HA, NP, and NS derived from a North American swine virus
isolate and the NA and M segment from an Eurasian lineage swine influenza virus 12. Further
reassortment events between PH1N1 and swine IAV have resulted in the creation of variant
H1N1v, H2N1v, and H3N2v viruses capable of causing disease in humans. All variant viruses
contain segment 7 (M) of PH1N1, which has been shown to confer aerosol transmissibility to
previously non-transmissible viruses 13,14. The widespread distribution of PH1N1 coupled with its
high rate of reassortment with environmental viruses suggests the potential for the emergence of
novel PH1N1 segment-containing IAV genome constellations with increased virulence or
transmissibility in humans.
North American H7N3 IAVs co-circulate with PH1N1; however, the ability of these avian
viruses to reassort with PH1N1, modify virologic traits, and induce disease in mammals is not
known. This study was initially designed to identify genome segments derived from diverse
avian- and human-origin IAV that were most compatible with an avian-origin LPAI (low
pathogenic avian influenza) H7N3 virus. We devised a competitive reverse genetics strategy to
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examine selection of a single genome segment when multiple versions of that segment are
present in a cell, mimicking cellular co-infection. We found PH1N1 PB2, NA, and M genome
segments are capable of outcompeting the parental H7N3 strain and additional heterologous
segments from diverse origins in competitive reverse genetic experiments. As a result of the
competitive reverse genetic studies, we generated and characterized the parental H7N3 and
P

H1N1 viruses, and seven H7N3:PH1N1 7+1 reassortant viruses. Characterization of single

segment reassortants demonstrated multiple genome segments from PH1N1 either enhanced
(PB2) or maintained (NA or M) H7N3 replication and virulence in a mouse model of infection.
Finally, adaptation of substituted PH1N1 segments was not required to function within the H7N3
backbone, suggesting these newly formed genomic constellations are genetically and
functionally stable.
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2.4 Materials and methods
Biosafety and Ethical Considerations
All experiments were carried out under enhanced BSL2 containment and approved by the
Washington University in Saint Louis Institutional Biosafety Committee. The H7N3 virus
A/shorebird/Delaware/22/2006 used in this study is neuraminidase inhibitor sensitive as are all
the reassortant H7N3 viruses that were generated and used in this study. Additionally, the
parental H7N3 virus has a genetic signature indicative of α-2,3-sialic acid (avian receptor)
binding preference and does not bear a multibasic cleavage site, therefore we did not reasonably
anticipate these experiments, in which this H7 HA was maintained, would result in increased
host range or transmission to a new (mammalian) host. Finally, the NA gene of
A/Memphis/03/2008 (H1N1) was excluded from this study due to a H274Y mutation that confers
resistant to neuraminidase inhibitors (16).
Viruses
Viruses used in this study: A/shorebird/Delaware/22/2006 (H7N3), A/California/04/2009
(PH1N1), A/mallard/Alberta/177/2004 (H7N9), A/Memphis/03/2008 (SH1N1), and A/Puerto
Rico/08/1934 (PR8H1N1). For SH1N1, H7N3, and H7N9, cDNA for all gene segments was cloned
into the bi-directional pHW2000 plasmid and used to generate influenza viruses as previously
described (17). Dr. Richard Webby at St. Jude Children’s Research Hospital kindly provided the
reverse

genetic

plasmids

for

P

H1N1

and

PR8

H1N1.

Plasmid-derived

A/shorebird/Delaware/22/2006 (H7N3), A/California/04/2009 (PH1N1), and all H7N3:PH1N1
7+1 single reassortant viruses, were generated using the 293T-Madin-Darby canine kidney cell
(MDCK) co-culture system and supernatant was injected into 10-day old embryonated chicken
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eggs for 48 hours at 35°C (Cackle Hatcheries, IA, USA). Allantoic fluid containing the
infectious virus was harvested and stored at -80°C. The viral titer (tissue culture infectious dose
50, TCID50) was determined using MDCK cells and viral stock used in this study was titrated at
least twice independently. Single reassortant viruses on the background of H7N3 possessing a
single genome segment from PH1N1 used in this study have been named with the following
convention – seven segments from the H7N3 virus plus the substituted PH1N1 segment in
subscript (ex. H7N3NA).
Cells
MDCK cells were maintained in Minimal essential medium (MEM) with 5% Fetal
bovine serum (FBS), vitamins, L-glutamine (Invitrogen), penicillin, and streptomycin. 293T cells
were maintained in Opti-MEM with 10% FBS, L-glutamine, penicillin and streptomycin. A549
cells were maintained in Dulbecco’s Minimal essential medium (DMEM) with 10% FBS
vitamins, L-glutamine, penicillin, streptomycin, 25mm HEPES, and non-essential amino acids
(NEAA).
Competitive Reverse Genetic Assay
A competitive reverse genetic assay was developed to evaluate the ability of avian and
human IAV genome segments to reassort in the context of an avian H7N3 viral background
(Figure 1A). 293T-MDCK co-cultures were transfected with pHW2000 plasmids (1 µg per
segment) containing seven genome segments of H7N3 virus plus four (for NA segment due to
exclusion of NA from sH1N1) or five plasmids encoding a single genome segment (e.g. PB2)
from different avian and human influenza viruses. All transfections included the wild-type H7N3
segment in addition to those from divergent strains. We did not evaluate the HA genome
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segment because of biosafety considerations. The total amount of co-transfected plasmid DNA
for the 8th segment (1 µg) was divided equally between the four or five studied viruses including
the parental strain. The DNA was mixed at a 1:2 ratio with Trans-IT LT1 (Mirus) in Opti-MEM
for 20 minutes at room temperature and added to the culture medium. Following an overnight
incubation, the cell culture medium was removed and 1ml of fresh Opti-MEM supplemented
with penicillin, streptomycin, L-glutamine was added. Twenty-four hours later an additional 1ml
of Opti-Mem with 1μg/ml TPCK-trypsin (Worthington) was added. Forty-eight hours later
supernatants were collected, cell debris removed by centrifugation at 1,200xg, and frozen at 80°C until further analysis. Clonal viral populations were isolated by limiting dilution assay on
MDCK cells, then viral RNA extracted, reverse-transcribed using a vRNA-specific primer, and
amplified with segment-specific PCR primers. Genome segment amplicons were genotyped by
either restriction fragment length polymorphism analysis (RFLP) or Sanger sequencing. RFLP
analysis was performed with one to four different restriction enzymes yielding a unique fragment
length pattern for each segment and strain: PB2 (EcoRI, HindIII, BamHI); PB1 (HindIII); PA
(BamHI, HindIII, XbaI); NP (BamHI, BglII); NA (BamHI, BglII, EcoRI, BsmBI); M (BamHI,
HindIII, XcmI, PvuII). All restriction enzymes were obtained from New England Biolabs and
used according to their instructions. The NS gene segment was genotyped by Sanger sequencing.
Competitive reverse genetic assays were completed at least twice independently for each genome
segment. On average we tested 48 clonal viruses per genome segment with a minimum of 24 (M
segment) and maximum of 71 (PA segment) viruses.
Virus Genome Sequence Analysis
After expansion of virus in eggs, the nucleotide identity of the singly substituted genome
segment in each H7N3:PH1N1 7+1 single reassortant virus was verified by Sanger sequencing.
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Viral genomic RNA was extracted, and reverse transcribed as described above. Segment-specific
PCR was conducted and the resulting amplicon was purified by Agarose gel electrophoresis, and
then submitted to for sequencing with an overlapping panel of sequencing primers derived from
the parental PH1N1 virus consensus sequence. We then assembled contiguous sequences for each
segment and aligned them to the parental segment for analysis. The same sample preparation and
analysis methods were used for materials derived from lung homogenate.
Multistep Growth Curves of Influenza A virus
MDCK or A549 cells (2x105) were seeded in 24-well plates and inoculated the next day
with 50 TCID50 (MDCK) or 105 TCID50 (A549) of IAV. MDCK cells were washed once with
PBS before adding the inoculum in MEM containing penicillin, streptomycin, L-glutamine, and
vitamins plus 0.1% bovine serum albumin (M0.1B) for one hour at 37°C. After the one hour, the
cells were washed once with PBS and 1.0 ml of M0.1B with 1µg/ml TPCK-trypsin was added to
each well. A549 cells were washed once in DMEM containing penicillin, streptomycin, Lglutamine, and vitamins plus 0.1% bovine serum albumin and NEAA (D0.1B) prior to
inoculation with virus diluted in D0.1B. After one hour at 37°C, the A549 cells were washed
once with D0.1B and 1.0 ml of D0.1B with 0.5µg/ml TPCK-trypsin was added to each well.
Culture supernatants from either cell type were collected at 24 and 48 hours post-infection (hpi)
and the amount of infectious virus was quantified by titration on MDCK cells. The results are the
average of two to three experiments, each performed in duplicate.
Phylogenetic analysis of IAV segments
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Phylogenetic trees were generated for complete genome segments using the ClustalW
algorithm in Lasergene MegAlign (version 11.1.0, DNASTAR, INC), bootstrapped 1000x, and
used to constructed neighbor-joining phylogenetic trees.
TCID50 assay
Confluent monolayers of MDCK cells were grown overnight in 96-well plates. The next
day, the cells were washed with PBS and inoculated with ten-fold serial dilutions (10-1 to 10-8) of
culture supernatant, allantoic fluid or lung homogenate for one hour in M0.1B at 37°C and 5%
CO2. After one hour the inoculum was removed and replaced with M0.1B supplemented with
1µg/ml TPCK-trypsin and incubated for 72 hours. Presence of virus was determined by
hemagglutination assay using 0.5% turkey red blood cells. TCID50 was determined by the ReedMuench method 15.
Intranasal inoculation of mice with influenza viruses
Six- to eight-week-old male C57BL/6J mice were bred in-house in a barrier facility at
Washington University School of Medicine, St Louis, MO, USA. The mice received food and
water ad libitum and all experiments were conducted in accordance with rules of the Institutional
Animal Care and Use Committee. Mice were inoculated with 103 or 104 TCID50 units of IAV
intranasally in 30 µl of sterile PBS after sedation with Avertin (2,2,2-tribromoethanol, SigmaAldrich, MO, USA). Morbidity and mortality following intranasal inoculation were monitored
for 7 days (104 TCID50) or 14 days (103 TCID50). To assess lung viral titers, mice inoculated with
104 TCID50 were sacrificed on days 3 or 7 post-inoculation, the entire lung was collected,
homogenized in 1.0 ml of infection media, cleared by centrifugation at 1000xg for 5 minutes and
stored in aliquots at –80°C. Experiments in which 104 TCID50 inoculum dose was used were
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terminated at 7 days post-inoculation as all mice survived to the this point, at which viral titration
and chemokine cytokine samples were harvested. Viral titers from lung homogenates were
determined by TCID50 assay. The results from the lung titrations are the average of at least two
independent experiments.
Cytokine Array
Cytokine and chemokine production in lung homogenates was measured using a 23-plex
cytokine array (Bio-Plex Pro™ Mouse Cytokine 23-plex Assay, Bio-Rad) according to
manufacturer’s protocol. The cytokine screen included IL-1α, IL-1β, IL-2, IL-3 IL-4, IL-5, IL-6,
IL-9, IL-10, IL-12p40, IL-12p70, IL-13, IL-17, Eotaxin, G-CSF, GM-CSF, IFN-γ, KC, MCP-1
MIP-1α, MIP-1β, RANTES, and TNF-α. As many samples fell below the limit of detection we
did not include the cytokines (IL-2, IL-3, IL-4, IL-9, and IL-17) in our analysis. Results from the
cytokine array are the average of at least two independent experiments (Day 3: H7N3WT,n=6;
H7N3PB2, n=5; H7N3NA, n=6, H7N3M, n=5; PH1N1WT, n=7; Day 7: H7N3WT, n=5; H7N3PB2, n=7;
H7N3NA, n=7; H7N3M, n=4; PH1N1WT, n=10).
Influenza A virus mini-genome reporter assay
The PB2, PB1, PA and NP genes from H7N3 and PH1N1 were cloned into the
pcDNA3.1+ (Invitrogen) mammalian expression vector from the corresponding pHW2000
plasmid. The PA of pH1N1 containing the P295L mutation was cloned from the reassortant
H7N3PA virus generated in this study. The pLuci plasmid was kindly provided by Dr. Yen (Hong
Kong University, Hong Kong, China) and contains the firefly luciferase gene flanked by the noncoding regions of NP gene segment in the negative orientation under the control of a human
RNA polymerase I promoter. Cells were maintained at 37°C for the duration of the experiment.
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A Renilla luciferase expression plasmid was included for normalization. 293T cells were seeded
into 24-well plates and transfected with PB2, PB1, PA and NP expression plasmids
(83ng/plasmid) along with the two luciferase containing plasmids (total of 500 ng DNA) using
TransIT LT1 per well. The following day the media was changed and cells were incubated for 48
hours, harvested and lysed for analysis of luciferase activities (Promega). Each combination of
polymerase proteins (set of plasmids) was examined in duplicate and repeated independently in
three separate experiments. The relative light units (RLU) of firefly luciferase activity were
normalized to the RLU for Renilla luciferase activity within the same sample to account
differences in transfection efficiency between wells and experiments. Polymerase activity was
normalized to that of the parental H7N3 polymerase proteins.
Statistical analysis
All statistical analyses were performed using GraphPad Prism 6.0 software. Mann-Whitney UTest was used to determine statistical significance between lung virus titers. One-Way ANOVA
with Dunnett’s Multiple Comparisons Test was used to determine statistical significance in
cytokine and chemokine production in lung homogenates, with all comparisons made to H7N3WT
for the indicated day. 2-Way ANOVA was used in the analysis of weight loss differences
following influenza A virus infections in mice. Student’s T-test was used to assess statistical
differences between conditions in the mini-genome reporter assay with all comparisons made to
the wild-type combination of H7N3 proteins.
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2.5 Results
A North American H7 virus preferentially selects avian and 2009 pandemic H1N1 genome
segments under competitive conditions.
Previous studies examining reassortment potential between H5- and H9- subtype avian
IAV and human-derived IAV report high compatibility between diverse avian and human origin
genome segments 2,4,16,17. However, it remains unclear if H7-subtype viruses can undergo similar
reassortment events with other avian and human IAV. The recent emergence of H7N9 in China
demonstrates that H7-subtype viruses can infect humans and, if they acquire the ability to
transmit between humans through reassortment, may pose a significant public health threat.
Therefore, we sought to determine if North American H7-subtype viruses are capable of
extensive reassortment with human or mammalian viruses.
We developed a competitive reverse genetics assay to evaluate the ability of heterologous
genome segments from human and avian viruses to reassort efficiently with a North American
low

pathogenic

H7N3

virus

(Figure

2.1

A).

Seven

genome

segments

of

A/shorebird/Delaware/22/2006 (H7N3) were maintained as a constant background while
multiple versions of the 8th segment from H7N3, A/California/04/2009 (PH1N1), A/Puerto
Rico/08/1934 (PR8H1N1), A/mallard/Alberta/144/2007 (H7N9), or A/Memphis/3/2008 (SH1N1)
were included in equimolar ratios. Phylogenetic trees were constructed for each genome segment
to illustrate the genetic relationship to the H7N3 segment (Figure 2.1 B). Pools of infectious
viruses were rescued, subjected to limiting dilution assays to culture clonal viral populations, and
identify the segment of interest by via RFLP or Sanger sequencing.
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A total of 334 viruses were analyzed for 7 genome segments in the context of H7N3 virus
(HA was excluded). We observed a high frequency of isolated viruses containing avian H7N3
(29%) or H7N9 (34%) derived genome segments (Figure 2.1 B). In particular, the PB1, PA, NP
and NS reassorted genome segments were predominantly (81%) of avian virus origin. In
contrast, when we examined the identity of competitively selected segments the PB2, NA, and M
genome segments were derived mostly from mammalian IAV, with a clear bias towards the
P

H1N1 virus. The NA gene of PH1N1 was identified in 100% (68/68) of the NA gene-reassorted

H7 viruses, while the M and PB2 gene segment constituted 55% (13/24), and 35% (14/37) of the
examined H7 viruses respectively. Combined, 32% of all isolated H7 viruses contained genome
segments derived from PH1N1, suggesting a high degree of compatibility between H7N3 and
P

H1N1 virus. Genome segments from PR8H1N1 were identified sporadically, 5% (15/334), among

the H7N3 viruses. Of these, 8 contained the PB2 gene of

PR8

H1N1. Finally, genome segments

from SH1N1 were never identified, 0% (0/266), among the H7 viruses, suggesting a low level of
genetic compatibility between human H1N1 viruses circulating prior to 2009 and avian H7N3
virus.
Most H7N3:PH1N1 7+1 viruses replicate efficiently in MDCK cells.
We observed a high degree of genetic compatibility between genome segments of PH1N1
and H7N3 viruses in our competitive reverse genetics assay and sought to determine the
replicative ability of each single reassortant virus bearing individual PH1N1 segments in the
background of H7N3. All 7+1 reassortant viruses were generated independently by reverse
genetics and amplified in chicken eggs. We inoculated MDCK cells with 50 TCID50 and
collected supernatant at 24 and 48 hpi (Figure 2.2 A and B, respectively). H7N3 virus replicates
to high titers at 24 (107.8/ml) and 48 hpi (107.9/ml). In contrast, PH1N1 virus replicates to
44

significantly lower titers at 24 (105.8/ml) and 48 hpi (106.4/ml) (P<0.01 for both time-points). H7
viruses containing the NA (H7N3NA) or M (H7N3M) gene segment of PH1N1 virus grow to
similar titers (P>0.2) at 24 hpi (107.6/ml for H7N3NA and 107.3/ml for H7N3M) and 48 hpi (108.2/ml
for H7N3NA and 108.1/ml for H7N3M). The titers of H7N3 reassortant viruses containing the PB2
(H7N3PB2, 106.8/ml), PA (H7N3PA, 105.9/ml), NP (H7N3NP, 105.7/ml) or NS (H7N3NS, 106.3/ml) gene
segment of PH1N1 were significantly (P<0.001) lower at 24 hpi, but not 48 hpi (P>0.15),
compared to H7N3 parental virus. Finally, the virus titer of H7N3PB1 was significantly (P<0.001)
lower at 24 and 48 hpi (104.4/ml and104.6/ml) compared to parental H7N3. Overall, our results
indicate that most H7N3 viruses possessing a single genome segment of PH1N1 are able to
replicate efficiently in a MDCK cell culture system and the NA and M gene of PH1N1 did not
attenuate H7N3 virus in vitro.
The majority of H7N3:PH1N1 7+1 viruses are attenuated in A549 cells.
Next, we measured replication of the 7+1 reassortant viruses in a human lung epithelial
cell line (A549). H7N3 virus replicated to 103.5 TCID50/ml at 24 hpi and 104.0 TCID50/ml at 48
hpi. PH1N1 virus replicated to equivalent titers at 24 hpi (103.7 TCID50/ml) and significantly
higher titers at 48 hpi (105.2 TCID50/ml, P<0.05) compared to H7N3 virus (Figure 2.2 C and D).
H7N3 virus containing the M-segment of pH1N1 (H7N3M) was able to grow in A549 cells, albeit
less efficient compared to the wild type H7N3 virus at 48 hpi (103.5 TCID50/ml, P<0.05). The
7+1 reassortant virus containing the PB2 genome segment of PH1N1 replicated to equivalently
titers at 24 hpi (103.7/ml), and higher titers at 48 hpi (104.7/ml, P<0.05), compared to H7N3 virus.
Finally, we did not detect replicating virus from the H7N3PB1, H7N3PA, H7N3NP, H7N3NA, or
H7N3NS reassortant viruses in culture supernatant at either time point post-inoculation. The data

45

suggest that the majority of the gene segments of PH1N1 attenuate H7N3 virus growth in human
cells.
PB2, PA, and NP segments of PH1N1 increase H7N3 polymerase activity in human cells.
We employed a mini-genome reporter assay to assess the polymerase activity of different
viral polymerase complexes in human 293T cells. We found that the full complement of PH1N1
proteins generated greater reporter activity than did the H7N3 polymerase proteins (1.8-fold
increase, P<0.01, Figure 2.3). Substitution of the PB2 or NP protein with those from PH1N1
increased polymerase activity by 1.8-fold (P<0.01) and 1.4-fold (P<0.001) respectively. The PA
of PH1N1 increased the polymerase activity more than 20-fold (P<0.001). We also evaluated a
PA protein of PH1N1 containing a Proline to Leucine substitution at position 295 (P295L). This
mutation was selected for in H7N3PA virus cultured in 10-day old embryonated chicken eggs.
The polymerase activity of the mutant PA remained more than 10-fold (P<0.001, Figure 2.3)
greater compared to H7N3 protein complex. Interestingly, substitution of PH1N1 PB1 into a
majority H7N3 polymerase complex resulted in a 25-fold reduction in polymerase activity
(P<0.001). To examine if this was due to strain-dependent differences in PB1 protein expression
we analyzed protein expression by flow cytometry (mean fluorescence intensity (MFI)) using
His-tagged versions of the PB1 of H7N3 and PH1N1 virus. We did not observe a difference in
MFI between these two proteins (data not shown), suggesting that the 25-fold difference in
reporter activity is due to inherent differences in compatibility between the polymerase proteins.
Overall, the H7N3 virus appears well adapted to mammalian cells and the introduction of the
PB1 of PH1N1 severely attenuates the H7N3 virus.
H7N3:PH1N1 7+1 reassortant viruses induce distinct morbidities in vivo.
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Given the high degree of functional compatibility between PH1N1 and H7N3 virus in
vitro, we next determined the relative fitness of these H7N3 viruses containing individual genesegments of PH1N1 in vivo. C57BL/6J mice were inoculated intranasally with either parental
(H7N3 or PH1N1) or single segment reassortant viruses and weighed at regular intervals for one
week (104 dose) or two weeks (103 dose) depending on the inoculum size. Mice inoculated with
104 TCID50 of H7N3 demonstrated substantial weight loss beginning at 3 dpi (10%) that
continued until the experiment was ended at 7 dpi (21%). Inoculation with 104 TCID50 of PH1N1
induced up to 30% weight loss relative to the starting weight within 7 days (Figure 2.4 A)
demonstrating that the PH1N1 is more pathogenic in mice compared to the avian H7N3 virus.
H7N3 viruses containing single gene segments for PH1N1 varied in their ability to cause weight
loss. Inoculation with 103 or 104 TCID50 of H7N3 virus containing the PB2 segment of PH1N1
induced significantly (P<0.05) more weight loss compared to H7N3, including rapid weight loss
(>20%) within the first three days following inoculation (Figure 2.4 A). Importantly, the
H7N3PB2 virus was significantly (P<0.005, days 8 and 10; P<0.01, days 12, and 14) less virulent
compared to the PH1N1 virus at the lower inoculum (Figure 2.4 D). Inoculation with 104
H7N3NA or H7N3M resulted in equivalent weight loss at all times compared to H7N3 (Figure 2.4
B, P>0.1). Reassortant H7N3 viruses possessing the PB1, PA, NP, or NS of PH1N1 did not
induce appreciable weight loss at any day post inoculation, suggesting that these gene-segments
from PH1N1 attenuate H7N3 virulence in vivo.
H7N3 reassortant viruses possessing PH1N1 PB2, NA, or M do not attenuate replication in
vivo.
To further evaluate the compatibility between H7N3 and PH1N1 viruses we measured
virus titer in lung tissue 3 and 7 dpi with 104 TCID50 of all parental and single gene reassortants.
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Lung viral titers 3 days after PH1N1 virus inoculation (106.4/ml) were significantly higher
(P<0.005) compared to H7N3 virus (105.9/ml, Figure 2.5 A). However, this difference in virus
load disappeared by day 7; H7N3 (105.3/ml) and PH1N1 (105.7/ml) (P>0.15, Figure 2.5 B). The
virus load in lungs of H7N3PB2 infected animals was significantly higher (106.5/ml, P<0.05) at 3
dpi, but not 7 dpi (105.0/ml, P>0.15), compared to H7N3 virus. Importantly, the viral load in
H7N3PB2 infected lungs was similar to that of PH1N1 virus at day 3. Inoculation with H7N3NA or
H7N3M resulted in similar lung virus titer compared to H7N3 at both 3 (105.7/ml for H7N3NA and
105.5/ml for H7N3M) and 7 dpi (105.2/ml for H7N3NA and 104.3/ml for H7N3M), (P>0.05 for all
comparisons). H7N3 reassortant viruses bearing PA or NS gene segment of PH1N1 replicated in
vivo, however the virus titers were significantly lower at 3 (104.0/ml for H7N3PA and102.2/ml for
H7N3NS, P<0.005 and P<0.01, respectively) and 7 dpi (102.0/ml for H7N3PA and102.0/ml for
H7N3NS, P<0.005 and P<0.005, respectively) compared to H7N3 virus (Figure 2.5 A and B).
Finally, H7N3NP and H7N3PB1 viruses were never detected at 3 or 7 dpi. These results suggest
that the PB2, NA and M genes of PH1N1 are genetically and functionally compatible with the
remaining segments of an avian H7 IAV.
P

H1N1 PB2, NA, or M show no signs of genetic adaptation in the context of a

predominantly H7N3 genome constellation.
We analyzed the nucleotide sequence of substituted PH1N1 gene segments in the context
of the H7N3:PH1N1 7+1 viruses after passage in eggs and replication in mice. Six of the seven
P

H1N1 gene-segments contained no nucleotide changes upon culture in eggs. A single point

mutation was found in the PA gene of PH1N1 (P295L) in H7N3PA grown 48 hours in eggs. This
same mutation was identified a second time following an independent attempt to rescue virus
with genetic sequence identical to the original PH1N1 PA gene. To analyze genetic stability in
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vivo, we isolated RNA from lungs of mice infected 7 days with H7N3PB2 (n = 3), H7N3NA (n = 3),
and H7N3M (n = 3). No nucleotide changes were found in any of the PB2, NA or M genes of
P

H1N1 in the context of the H7N3 virus. Taken together, these data suggest that the PH1N1 gene

segments are genetically stable and highly functional in the context of an avian H7N3 virus.
H7N3 and reassortant viruses that contain PH1N1 PB2, NA, or M viruses induce robust
inflammatory cytokine and chemokine responses in vivo.
The virulence and fitness of an influenza virus in the mouse model is often associated
with elevated production of pro-inflammatory cytokines and chemokines

18–20

. To further

evaluate the functional compatibility between PH1N1 and H7N3 genes we quantified the
inflammatory response in lung tissue 3 and 7 days post inoculation with the three most virulent
H7N3:PH1N1 7+1 reassortant viruses (H7N3PB2, H7N3NA, and H7N3M) and compared the
response to that of parental H7N3 and PH1N1 virus. The parental H7N3 virus induced
significantly (P<0.05) higher concentrations of inflammatory mediators, such as IL-12(p40)
early following inoculation (day 3) relative to PH1N1 (Table 2.1). Infection with H7N3PB2
induced higher concentrations of key inflammatory mediators including CCL2, CCL3, and
CCL5 relative to H7N3 (P<0.05). H7N3PA replication was attenuated in vivo and this virus
correspondingly induced significantly lower levels of many inflammatory cytokines relative to
H7N3 (P<0.05). By 7 days post infection, PH1N1 infected lungs had higher concentrations of
cytokines relative to parental H7N3 while H7N3PB2 produced even more exacerbated responses
in many mediators, including IL-10, CCL2, CCL3, CCL5, and TNF-α (P<0.05-P<0.001 relative
to H7N3, Table 2.2). H7N3NA and H7N3M elicited inflammatory responses that more closely
resemble the profile of H7N3 than PH1N1 at both time points following infection.
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Table 2.1. Inflammatory cytokine and chemokine levels in total lung homogenates three
days after intranasal inoculation with parental H7N3, PH1N1, and reassortant viruses.
Concentration (pg/ml) (mean ± S.E.M.) in mouse lung
Cytokine
IL-1α
IL-1β
IL-5
IL-6
IL-10

Virus
H7N3WT
267 ± 5
360 ±
294 ± 95
228 ± 69
21 ± 3

H7N3PB2
32 ± 4
436 ± 57
529 ± 56
363 ± 78
20 ± 2

H7N3NA
23 ± 6
494 ± 73
423 ± 45
451 ± 49*
16± 2

H7N3M
33 ± 7
498 ± 66
356 ± 58
288 ± 57
20 ± 2

IL-12p40
253 ± 63 421 ± 65
244 ± 36
383 ± 51
IL-12p70
100 ± 27 48 ± 7
44 ± 8
55 ± 12
#
IL-13
52 ± 3
64 ± 5
45 ± 5
48 ±5
Eotaxin
462 ± 97 613 ± 24
732 ± 60*
570 ± 107
G-CSF
268 ± 78 579 ± 113* 336 ± 92
263 ± 22
GM-CSF
67 ± 11
65 ± 5
57 ± 6
50 ± 6
&
Interferon-γ 9 ± 1
20 ± 3
7±1
9±3
KC
370 ± 88 435 ± 119
456 ± 95
533 ± 52
&
CCL2
586 ±
3145 ±
1115 ± 84
758 ± 99
CCL3
52 ± 16
125 ± 18*
77 ± 24
65 ± 21
CCL4
72 ± 20
128 ± 34
84 ± 17
68 ± 6
CCL5
89 ± 13
148 ± 27*
125 ± 25
105 ± 31
TNF-α
172 ± 49 123 ± 12
126 ± 21
100 ± 9
(*, P < 0.05; #, P < 0.01; &, P < 0.005, compared to H7N3 values).
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PH1N1WT

12 ± 5*
169 ± 22
29 ± 13*
70 ± 30
13 ± 4
85 ± 24*
63 ± 36
26 ± 3&
175 ± 25
249 ± 91
46 ± 13
5 ± 1*
151 ± 56
835 ± 292
22 ± 8
44 ± 8
66 ± 24
262 ± 52

Table 2.2. Inflammatory cytokine and chemokine levels in total lung homogenates seven
days after intranasal inoculation with parental H7N3, PH1N1, and reassortant viruses.
Concentration (pg/ml) (mean ± S.E.M.) in mouse lung
Virus
Cytokine
H7N3WT H7N3PB2
H7N3NA
H7N3M
&
IL-1α
13 ± 1
48 ± 4
22 ± 8
32 ± 2&
IL-1β
313 ± 80 669 ± 77
337 ± 99
840 ± 51*
IL-5
131 ± 35 120 ± 23
313 ± 95
178 ± 36
IL-6
198 ± 39 148 ± 35
355 ± 105
183 ± 45
IL-10
62 ± 6
247 ± 63*
76 ± 27
109 ± 16
IL-12p40
328 ± 78 462 ± 66
218 ± 52
713 ± 122*
IL-12p70
44 ± 9
104 ± 24*
63 ± 10
37 ± 3
&
IL-13
92 ± 14
248 ± 19
92 ± 16
193 ± 10&
Eotaxin
1678 ±
465 ± 89
464 ± 94
432 ± 88
G-CSF
288 ± 53 289 ± 87
333 ± 127
490 ± 141
#
GM-CSF
46 ± 6
80 ± 7
37 ± 3
105 ± 4&
Interferon-γ 46 ± 12
63 ± 27
24 ± 18
51 ± 1
KC
196 ± 65 351 ± 54
284 ± 130
153 ± 59
CCL2
750 ± 25 2580 ±610* 402 ± 198
201 ± 114*
#
CCL3
172 ± 18 2544 ± 610 96 ± 35
737 ± 243
CCL4
196 ± 41 156 ± 35
99 ± 63
69 ± 13*
CCL5
692 ± 78 1672 ±333* 271 ± 193
593 ± 116
TNF-α
161 ± 27 478 ± 99*
221 ± 44
167
(*, P < 0.05; #, P < 0.01; &, P < 0.005, compared to H7N3 values).
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PH1N1WT
&

31 ± 2
519 ± 112
235 ± 35
790 ± 85&
123 ± 12#
313 ± 39
82 ± 14*
123 ± 44
393 ± 55
1362 ± 105&
152 ± 85
276 ± 96*
338 ± 80
2273 ± 288&
692 ± 171*
110 ± 20
294 ± 65#
307 ± 35#

2.6 Discussion
The ongoing reassortment of avian and human IAV threatens human populations
worldwide as evidenced by numerous recent zoonotic events

21

. Along with H5- and- H9

subtypes, H7-subtype viruses are thought to be candidates for generating a pandemic IAV. We
sought to determine the potential for reassortment between a low-pathogenic North American
avian H7N3 virus and diverse avian and mammalian virus isolates. Our studies identified a clear
bias towards reassortment of H7N3 with gene-segments derived from the 2009 pandemic H1N1
(PH1N1) virus, but not other mammalian virus isolates. We found that single reassortant H7N3
viruses containing PB2, NA, or M segments of PH1N1 do not attenuate the H7N3 virus in vitro
or in vivo. Our results highlight the potential for environmental reassortment that can lead to
antigenically novel viruses capable of inducing disease in mammals and may inform future
surveillance efforts. Moreover, these findings support the potential for emergence of future prepandemic viruses in avian populations without prior mammalian adaptation.
We used a novel plasmid-based genetic screen to assess the compatibility of human and
avian genome segments in the context of a low-pathogenic North American H7N3 virus. We
found that PH1N1 genome segments were selected most frequently among mammalian derived
segments, suggesting a high degree of functional compatibility of these segments with the H7N3
virus when compared to pre-pandemic human isolates. We found no instances of seasonal H1N1
(SH1N1) gene segments reassorting with the avian virus and only seldom observed inclusion of
genes from the

PR8

H1N1 strain. This striking difference suggests that the current H1N1 virus

(PH1N1) is more likely to reassort with other viruses and create novel pandemic viruses. While
the mechanism underlying this preference is unknown, it is plausible that the extended adaptation
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of gene-segments of SH1N1 to the human host and other segments of SH1N1 has decreased its
ability to reassort with avian or other human viruses. In contrast, gene-segments of PH1N1 are
found in many different virus isolates validating the ability to reassort rapidly with other strains
of influenza virus.
We observed a high frequency of H7N3 and H7N9 segment selection in instances when
these segments were closely related (Figure 2.1 B). However, in not all instances did high
nucleotide similarity to the parental H7N3 segment result in high rates of selection, for example
the M and NA segments of PH1N1 virus. This discrepancy perhaps indicates, that within this
system, compatibility between proteins, not genome segments, drives viral replication and
therefore selection.
Historically, reassortment of influenza viruses was studied using co-infection models.
These experiments provided important information about the natural evolution of IAV; however,
they are less controlled and potentially more hazardous if one or both IAVs have previously been
shown to transmit between mammals. We provide an alternative method to study influenza
reassortment and argue that these experiments are not only safer, but also address a different
question and that is; what are the molecular requirements of a single gene-segment to compete
with and reassort into an existing virus genome? Knowing the key features in a genome segment
that promotes or inhibits reassortment will result in a better understanding of the process as a
whole and therefore improve our predictions on the outcome of experimental and natural coinfections.
These studies identified two pandemic IAV gene segments, NA and M, which in the
context of H7N3 virus do not impact viral replication in MDCK cells or pathogenesis in mice.
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The compatibility of these genes with H7N3 is of interest given their prior association with
increased transmission of the 2009 pandemic H1N1 when compared with putative pandemic
progenitors 22. Multiple independent reassortment events between human and swine influenza
viruses resulted in the creation of novel genome constellations (H1N1v, H2N1v, and H3N2v)
capable of aerosol transmission from pig to human due to acquisition of PH1N1 M. Previous
investigations of potential reassortant viruses between a highly pathogenic avian H5N1 influenza
virus and PH1N1 demonstrated high compatibility between H5N1 and the NA and M segments of
P

H1N1

23

. The resulting reassortant viruses similarly did not have altered in vitro replication

relative to wild-type H5N1 virus. To further experimentally corroborate the importance of this
segment in PH1N1 transmission, multiple studies engineered reassortant viruses that either
gained or lost the ability to transmit between mammals following manipulation of M

22,24

. In

combination with M, NA was capable of enhancing the transmission of PH1N1 through altered
receptor destroying activity (NA) and filamentous particle morphology (M) that changes virus
release from the respiratory tract of infected animals compared to diverse contemporary swine
isolates. Although our studies did not examine virion morphology or respiratory shedding,
additional studies in a model more suitable for examining such phenotypes may provide insights
into the activity of these genes in the genetic background of an avian influenza virus.
The potential for transmission of H7-bearing viruses has been demonstrated
experimentally

25

. Since other North American H7-HA are able to bind both avian and

mammalian receptors, additional adaptations or acquisition of other gene segments via
reassortment may be critical to achieve sustained mammalian transmission 26–28. Other avian viral
subtypes (i.e. H9N2 and H5N1) can reassort with PH1N1 and achieve contact or respiratory
droplet transmission

2,4,16

. Additionally, reassortant viruses possessing PH1N1 M are capable of
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directly infecting humans from pigs 29. Our studies show H7N3 viruses possessing PB2, NA, or
M from PH1N1 are not attenuated in vivo and induce disease comparable to wild type H7N3
without adaptation. Further studies of these viruses and other similar single reassortant avian
viruses in mammalian transmission models are required to understand the constellation of
reassortants that are potential sources of new zoonoses.
PB2 is the only PH1N1 gene segment that increased the virulence and replication in vivo
relative to wild type H7N3 despite attenuation in vitro. Previous studies have identified several
amino-acid substitutions that are associated with efficient replication in mammalian cells,
including G590S, Q591R, E627K, and D701N 30–32. The PB2 of H7N3 virus contains all avian residues,
while the PB2 of PH1N1 has the G590S and Q591R substitution. Based on this information, we
anticipated that the PB2 of PH1N1 would increase replication of the H7N3 7+1 virus in
mammalian cells. As increased viral replication may exacerbate initial inflammatory responses
and lead to subsequent morbidity

18,20

, we assessed the abundance of cytokines and chemokines

present in whole lung homogenate at two points following infection (Tables 2.1 and 2.2).
Mammalian adapted PH1N1 PB2 increased induction of pro-inflammatory cytokines IL-6, CCL2
and CCL3 early during infection (day 3, Table 2.1). CCL2 levels also correlated well with
morbidity when assessed later during infection at 7 dpi, likely due to increased viral replication
early following inoculation (Table 2.2). Importantly, while morbidity and viral titer were
increased relative to parental H7N3, substitution of PH1N1 PB2 did not induce morbidity
equivalent to parental PH1N1 at low inoculum dose.
While most H7N3 7+1 reassortant viruses did not contain mutations in the PH1N1 genesegment, we repeatedly recovered H7N3PA virus containing an amino acid substitution at position
295 (P295L). In a unique isolate from the 2009 pandemic – A/Tennessee/560/09 (H1N1)- mouse
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adaptation introduced the inverse mutation PA L295P 33. Upon further examination, creation of a
virus with only this mutation led to increased viral replication in normal human bronchial
epithelial (NHBE) cells. In a different study, the same group described L295P as contributing to
increased and prolonged viral shedding and disease in both donor and contact ferrets34.
Additionally, the same polymerase assay that we utilized, A/Tennessee/560/09 PA L295P
increased reporter activity in the context of other A/Tennessee/560/09 proteins and the coexpressed level of PB2 but not of NP 33. The importance of this residue had not to our knowledge
been examined in the context of A/California/04/09 PA before this report, though it may be
surmised that the P295L mutation is detrimental to the PA function in the mammalian host and
perhaps was selected for due to interaction with the avian host during growth in chicken eggs or
with a component of the H7N3 polymerase complex.
In the context of the H7N3 polymerase complex, this mutation reduced the polymerase
activity 2-fold (Figure 2.3). At this time we cannot address if the observed differences in
polymerase activity are due to altered protein half-life, expression level, or inherent enzymatic
activity of PH1N1 PA in either H7N3 or PH1N1 complexes. It is not known if this mutation
affected the virulence of H7N3PA in mice, but based on published data we expect that an H7N3
virus containing the wild-type PA of PH1N1 is even more attenuated.
Taking the data together, we establish that the 2009 pandemic H1N1 has a high degree of
compatibility with a North American LPAI H7N3 virus. Further, the genome segment reassortant
viruses containing the PH1N1 segments most frequently selected (PB2, NA, or M) establish
productive infection in the mouse respiratory tract, induce morbidity and disease, and persist for
at least one week, potentially allowing dissemination to others by contact or respiratory
transmission. Future studies may examine the potential for transmission of these H7 viruses
56

containing single genes from 2009 pandemic H1N1. These studies emphasize the need for
continued surveillance of the avian IAV reservoir and the critical importance of identifying
reassortant viruses that contain genomic signatures associated with mammalian disease and
transmission.

57

2.7 Acknowledgements
G.D.W. was supported in part by training grant GM: 007067, the Victoria J. Fraser, M.D.
Fellowship for Graduate Studies in Infectious Diseases, and the Division of Biology and
Biomedical Sciences at Washington University School of Medicine. Finally, we are thankful for
the technical assistance of Traci Bricker.

58

59

Figure 2.1.

A North American H7N3 virus preferentially selects avian and 2009

pandemic H1N1 genome segments following competitive transfection.
A. Seven genome segments derived from A/shorebird/Delaware/22/2006 (H7N3) were cotransfected with four (NA only) or five variants of the eighth genome segment. These variants
included the homologous gene-segment from A/shorebird/Delaware/22/2006 (H7N3) as well as
that

of

A/mallard/Alberta/177/2004

(H7N9),

A/Memphis/03/2008

(SH1N1),

A/California/04/2009 (PH1N1), and A/Puerto Rico/08/1934 (PR8H1N1) virus. Following
transfection, individual virus particles were cultured in MDCK cells using a limiting dilution
assay. Virus positive wells were identified by HA assay and the remaining supernatant was used
to purify viral RNA. cDNA was generated using a universal influenza primer and the segment of
interest was amplified using segment-specific PCR primers and analyzed by restriction length
fragment polymorphism (RFLP). B. Pie charts depicting the relative distribution of four or five
gene-segments that were identified among the competitive reverse genetics derived H7 viruses.
The results are the cumulative distribution of two or more independently repeated experiments;
334 viruses in total sampled. The NA gene of A/Memphis/03/2008 (NA-inhibitor insensitive)
was excluded from these analyses. Phylogenetic trees for each corresponding segment
illustrating the genetic relationship to between segments assayed (bootstrapped 1000x). The line
beneath each phylogenetic tree represents 1 nucleotide substitution per 100 nucleotides.
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Figure 2.2.

Several H7-single gene reassortant viruses possessing a PH1N1 segment

replicate to efficiently in mammalian tissue culture.
MDCK cells were inoculated with 50 TCID50 of the indicated virus and virus titer (TCID50/ml) in
the supernatant was determined at 24 (A) or 48 (B) hours post- inoculation by virus titration
assay on MDCK cells. A549 cells were inoculated with 105 TCID50 of the indicated virus and
virus titer (TCID50/ml) in the supernatant was determined at 24 (C) or 48 (D) hours postinoculation by virus titration assay on MDCK cells. The limit of detection was 100 TCID50
(dotted line). The data represent the geometric mean + the standard error of the mean of four
samples derived from two or three independent experiments performed in duplicate (*, P<0.05;
**, P<0.01; ***, P<0.005, compared to H7N3 values).
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Figure 2.3.

PA protein from pandemic H1N1 virus increases polymerase activity of

H7N3 in human 293T cells.
A. A reporter assay was used to measure the relative polymerase activity of different polymerase
protein complex combinations between H7N3 and PH1N1 viruses, including PH1N1 PA P295L as
described in the Materials and Methods. The relative polymerase activity was first normalized to
the Renilla activity and compared to that of a full set of H7N3 polymerase proteins. Blue boxes
represent H7N3 proteins, white boxes represent pH1N1 proteins, and spotted white boxes
represent pH1N1 PA-P295L. Data represent the average normalized value from three or five
experiments performed in duplicate (*, P < 0.05; **, P < 0.01; ***, P < 0.005, compared to
H7N3 values).
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Figure 2.4.

Reassortant H7 viruses containing PH1N1 PB2, NA, or M induce

considerable morbidity in mice
(A-C). Groups of male C57BL/6J were inoculated intranasally with 104 TCID50 of the indicated
viruses and weight loss was measured for 7 days. Morbidity is displayed as percent of original
body weight remaining for mice inoculated with the indicated virus that showed significantly
greater (A), equal (B), or significantly less (C) weight loss than the parental H7N3 virus. (D)
Male C57BL/6J mice were inoculated intranasally with 103 TCID50 of H7N3, PH1N1 or H7N3
containing the PB2 of PH1N1 (H7N3PB2) and weight loss was measured for 14 days. The data
represents the average and standard error of the mean of at least six animals from two or more
independently performed experiments per virus. (*, P < 0.05; **, P < 0.01; ***, P < 0.005,
compared to H7N3 values; #, P < 0.05; ##, P < 0.01; ###, P < 0.005; ####, P < 0.001,
compared to PH1N1 values).
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Figure 2.5.

H7N3 replicates extensively in the lungs of C57BL/6J mice and PH1N1 PB2,

NA, or M do not attenuate H7N3.
Male C57BL/6J mice were inoculated with 104 TCID50 of H7N3, PH1N1, or the indicated
reassortant virus and lung viral titers were quantified 3 and 7 days post inoculation. Virus titer
present in whole lung homogenate at day 3 (A) or day 7 (B) was determined by virus titration
assay on MDCK cells and expressed as TCID50/ml. Viral titers were derived from five or more
mice from two or more independently performed experiments. The limit of detection was 100
TCID50 (dotted line). (*, P < 0.05; **, P < 0.01; ***, P < 0.005, compared to H7N3 values.)
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Chapter 3:
Amino Acid Identity Affects Competitive
Incorporation of influenza A Genome
Segments and Limits the Potential for
Reassortment

74

3.1 Abstract
Influenza A virus (IAV) reassortment leads to the generation of new viral strains
including those with pandemic potential. The segmented nature of the viral genome allows copackaging of viral genomic RNA from multiple parental strains upon cellular co-infection.
Previous studies have identified so-called packaging signals at the distal ends of each vRNA
segment as determinants of selective packaging of reporter RNAs into viral particles. More
recently vRNA bundling signals and other structural sequence elements that lie outside of these
canonical packaging elements were implicated in the selection of divergent RNA species. Here
we utilize a recently developed competitive reverse genetics strategy to comprehensively assess
the potential for reassortment between genetically diverse virus segments in the context of an
isogenic background commonly used in laboratory and vaccine development settings. Initially,
we show that competition occurs in vitro in a genome context-dependent manner. We then
determine the n-terminal region outside of known packaging elements of segment 3 (PA) is a
determinant of selection. These experiments simultaneously reveal inherent flexibility of the
viral genome while illuminating sequences that are important for selective packaging during coinfection. Finally, we examine the nucleotide and amino acid identities within segment 3 that
drive the preferential selection of one strain’s segment over another. Taken together we establish
the amino acid identity of PA-184, as an important human-specific determinant of polymerase
activity and competitive selection in this system.
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3.2 Introduction
Influenza A viruses (IAV) belong to the orthomyxovirus family. These viruses possess a
genome composed of eight single-stranded negative-sense RNA segments encapsulated in a
nucleoprotein coat and polymerase complex packaged in a host-cell derived envelope1. In the
event of cellular coinfection, viral ribonucleoprotein complexes (vRNPs) from multiple strains of
the virus are able to simultaneously utilize the host cell for replication and genome packaging2. If
a mixed genome is successfully packaged, resulting viruses with segments from both parental
strains result - giving rise to a new genome constellation3. This process, termed reassortment, is
one of the evolutionary strategies employed by IAV to produce new viral strains that may have
altered replication, pathogenesis, and transmission profiles when compared to previous isolates.
For reassortment to be successful new genomic constellations must be replication competent and
when there is little difference between constituent segments of two viruses reassortment may
occur at a high frequency2. Importantly, reassortment may result in progeny viruses with mixed
genomes that possess a combination of virologic traits that induce shifts in host adaptation,
transmission potential, and pathogenesis4.
Influenza reassortment has lead to the generation of multiple viruses capable of
generating pandemics. Requisite for pandemic formation is the ability of the virus to break
animal-to-human transmission barriers, replicate and release efficiently in the human host, and
transmit form human-to-human. The profound effect of reassortment may be illustrated by
inspecting the phylogeny of pandemic IAVs from 1918 to 2009 and the recently emergent
H7N95. In each case an antigenically distinct HA was acquired by way of reassortment with a
virus capable of transmitting to and replicating in humans. Humoral immunity to HA is the
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primary basis of current vaccination strategies and antigenic shift of HA by reassortment alters
recognition by antibodies6. The 1918 H1N1 "Spanish Flu" was likely created by reassortment of
at least one avian virus and a mammalian virus that circulated in porcine hosts before
introduction to humans7. Between 20-50 million people died as a result of primary influenza
infection and subsequent secondary pneumonia. Contemporary segments with high homology to
the 1918 H1N1 strain persist in both avian and swine populations8. Experimental creation of an
H1N1 strain derived from currently circulating avian genome segments was also shown to cause
severe disease in mammals and can transmit between ferrets9. Moreover, reassortment between
human and avian influenza A viruses, likely in a porcine vessel, resulted in the generation of
H2N2 and H3N2 strains that caused pandemics in 1957 and 1968, respectively. H3N2 viruses
have continued to circulate following the pandemic and are, along with H1N1, the primary cause
of seasonal epidemics7,10.
Prior to each pandemic, antigenic shift of external proteins occurred in addition to
transfer of internal gene segments. The 2009 pandemic H1N1 emerged following at least three
independent reassortment events involving human, porcine, and avian viruses. In each recent
human pandemic the PB2 and PA segments co-segregated in part due to a requirement for
interacting viral protein interfaces. Co-segregation of H3N2 and H1N1 PB2 and PA segments
has been demonstrated experimentally using high-content reassortment assays with replicating
viruses11. Additionally, the interdependence of PB2 and PA residues has been interrogated
extensively in vitro utilizing co-transfection mini-genome assays to assess the amino acid
residues responsible for polymerase complex activity in the context of reassortant protein
complexes. Utilizing phylogenetic data from human and avian strains, interdependence on amino
acid residues 184 and 383 in the PA subunit were required for an H1N1 PA to be able to
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replicate genome in the context of a polymerase complex otherwise derived from an H3N2
isolate12.
Here, we utilize a competitive reverse genetics system to identify differences genetic
restriction of closely related avian gene segments in the context of a H1N1 virus in human
cells13. We identify specific polymerase complex combinations in the context of replicating virus
and map this activity to a specific genetic locus in PA14. Prior studies have focused on the
restriction of reassortment between H3N2 and H1N1 viruses, whereas we explore why certain
otherwise functional avian genes are non-permissively excluded from H1N1 viruses during
competition. We find, that the identity of amino acid 184 dictates the ability of an avian H7N3
PA genome segment to be incorporated into a H1N1 isolate descended from the 1918 pandemic
H1N1. Additionally, the selection bias demonstrated during reverse genetic competition assays
may be alleviated by addition of the heterologous H7N3 PB2 segment, indicating a specific
interplay between these two elements. Manipulation of the H1N1 PA-184 residue attenuated
virus replication in human, but not canine cells and this can be attributed to diminished
polymerase activity. Restoration of the H1N1-like PA-184 residue increases the polymerase
activity of H7N3 PA and relative competitive incorporation rate when compared to the H1N1
virus, indicating that this amino acid is a species-specific and context-dependent regulator of
reassortment potential.

78

3.3 Materials and methods
Biosafety Considerations
All reverse genetic experiments were carried out in the BSL2+ setting, within a class II
biosafety hood, utilizing appropriate personal protective equipment. All experiments were
discussed with Washington University in Saint Louis’s Institutional Biosafety Committee (IBC)
and approved by the biosafety officer.
Viruses

Viruses used in this study: A/shorebird/Delaware/22/2006 (H7N3), A/California/04/2009
(PH1N1), A/mallard/Alberta/144/2007 (H7N9), A/Memphis/03/2008 (SH1N1), and A/Puerto
Rico/08/1934 (PR8H1N1). For SH1N1, H7N3, and H7N9, cDNA for all gene segments was cloned
into the bi-directional pHW2000 plasmid and used to generate influenza viruses as previously
described (see Chapter 2). Dr. Richard Webby at St. Jude Children’s Research Hospital kindly
provided the reverse genetic plasmids for PH1N1 and

PR8

H1N1. Plasmid-derived A/Puerto

Rico/08/1934 (H1N1), A/shorebird/Delaware/22/2006 (H7N3), and all

PR8

H1N1 7+1 single

reassortant viruses, were generated using the 293T-Madin-Darby canine kidney cell (MDCK) coculture system and supernatant was injected into 10-day old embryonated chicken eggs for 48
hours at 35°C (Cackle Hatcheries, IA, USA). Allantoic fluid containing the infectious virus was
harvested and stored at -80°C. The viral titer (tissue culture infectious dose 50, TCID50) was
determined using MDCK cells and viral stock used in this study was titrated at least twice
independently. Single reassortant viruses on the background of

PR8

H1N1 possessing a single

genome segment from H7N3 used in this study have been named with the following convention
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– seven segments from the

PR8

H1N1virus plus the substituted H7N3 segment in subscript (ex.

PR8:PAH7N3).
Cells
MDCK cells were maintained in Minimal essential medium (MEM) with 5% Fetal
bovine serum (FBS), vitamins, L-glutamine (Invitrogen), penicillin, and streptomycin. 293T cells
were maintained in Opti-MEM with 10% FBS, L-glutamine, penicillin and streptomycin. A549
cells were maintained in Dulbecco’s Minimal essential medium (DMEM) with 10% FBS
vitamins, L-glutamine, penicillin, streptomycin, 25mm HEPES, and non-essential amino acids
(NEAA).
Competitive Reverse Genetic Assay
We utilized a previously developed competitive reverse genetic assay to evaluate the
ability of avian and human IAV genome segments to reassort in the context of a

PR8

H1N1 viral

background (Figure 1A). 293T-MDCK co-cultures were transfected with pHW2000 plasmids (1
µg per segment) containing seven genome segments of PR8H1N1 virus plus four (for NA segment
due to exclusion of NA from sH1N1) or five plasmids encoding a single genome segment (e.g.
PB2) from different avian and human influenza viruses. All transfections included the wild-type
PR8

H1N1 segment in addition to those from divergent strains. We did not evaluate the HA

genome segment because of biosafety considerations. The total amount of co-transfected plasmid
DNA for the 8th segment (1 µg) was divided equally between the four or five studied viruses
including the parental strain. The DNA was mixed at a 1:2 ratio with Trans-IT LT1 (Mirus) in
Opti-MEM for 20 minutes at room temperature and added to the culture medium. Following an
overnight incubation, the cell culture medium was removed and 1ml of fresh Opti-MEM
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supplemented with penicillin, streptomycin, L-glutamine was added. Twenty-four hours later an
additional 1ml of Opti-Mem with 1μg/ml TPCK-trypsin (Worthington) was added. Forty-eight
hours later supernatants were collected, cell debris removed by centrifugation at 1,200xg, and
frozen at -80°C until further analysis. Clonal viral populations were isolated by limiting dilution
assay on MDCK cells, then viral RNA extracted, reverse-transcribed using a vRNA-specific
primer, and amplified with segment-specific PCR primers. Genome segment amplicons were
genotyped by either restriction fragment length polymorphism analysis (RFLP) or Sanger
sequencing. RFLP analysis was performed with one to four different restriction enzymes
yielding a unique fragment length pattern for each segment and strain: PB2 (EcoRI, HindIII,
BamHI); PB1 (HindIII); PA (BamHI, HindIII, XbaI); NP (BamHI, BglII); NA (BamHI, BglII,
EcoRI, BsmBI); M (BamHI, HindIII, XcmI, PvuII). All restriction enzymes were obtained from
New England Biolabs and used according to their instructions. The NS gene segment was
genotyped by Sanger sequencing. Competitive reverse genetic assays were completed at least
twice independently for each genome segment.
Multistep Growth Curves of Influenza A virus
2x105 MDCK cells were seeded in 24-well plates and infected the next day at MOI 0.001.
Briefly, MDCK cells were washed once with PBS before adding the inoculum in Minimal
Essential Medium (MEM) containing penicillin, streptomycin, glutamine, and vitamins plus
0.1% bovine serum albumin (M0.1B) for one hour at 37°C. After the one hour, the cells were
washed with PBS and 1.0 ml of M0.1B with 1µg/ml TPCK-trypsin (Worthington Technologies)
was added to each well. Culture supernatants were collected at 24 and 48 post infection and the
amount of infectious virus was quantified by titration on MDCK cells. All growth curve
experiments were performed at least twice in duplicate. Infection of 293T cells was performed in
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24-well plates coated with poly-D-lysine to enhance cellular adherence with each well containing
2x105 cells. Infection of cells was performed at MOI 0.1 and samples collected from supernatant
at 24 hours. One hour post-infection, inoculum was removed, cells washed once with PBS, and
fresh M0.1B media containing 0.4 µg/ml TPCK-trypsin was added to the culture.
Generation of mutants
Chimeric segments were generated by creation of fragments that carried BsmBI (New
England Biosciences) restriction sites to allow scar-less integration of unique pieces. All singlemutant pHW2000 plasmids were generated by use of the Agilent Quick Change II system
according to the manufacturer’s protocol. Sequence identity of all newly generated chimeric and
mutant plasmids was verified by sequencing. All viruses were additionally examined for rescue
capacity in the PR8H1N1 background and successfully generated.
Mini-genome luciferase assay with polymerase genes of influenza A virus
The PB2, PB1, PA and NP genes from

PR8

H1N1 and H7N3 were previously cloned into the

pHW2000 vector. The pLuci plasmid was kindly provided by Dr. Yen (Hong Kong University,
Hong Kong, China) and contains the firefly luciferase gene flanked by the non-coding regions of
NP gene segment in the negative orientation. The transcription of this influenza A virus-like
gene segment is under the control of a human polymerase I promoter. A Renilla luciferase gene
containing expression plasmid is used to normalize for transfection efficiency. 293T cells are
transfected with plasmids containing the PB2, PB1, PA and NP gene segments of IAV plus the
two luciferase containing plasmids (500ng total DNA) using TransIT LT1 (Mirus Bio LLC). The
next day the media was changed and the assay was incubated for 48 hours from the time of
transfection before the cells were harvested, lysed and used to analyze Firefly and Renilla
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luciferase activity (Promega). Each condition (set of plasmids) was done in duplicate and
repeated independently in separate experiments three times. The relative light units (RLU) of
firefly are normalized to the RLU for Renilla and the activity of varying polymerase
combinations are then normalized to that of the full complement of

PR8

H1N1 IAV segments

within each experiment.
TCID50 assay
Confluent monolayers of MDCK cells were grown overnight in 96-well plates. The next
day, the cells were washed with PBS and inoculated with ten-fold serial dilutions (10-1 to 10-8) of
culture supernatant, allantoic fluid or lung homogenate for one hour in M0.1B at 37°C and 5%
CO2. After one hour the inoculum was removed and replaced with M0.1B supplemented with
1µg/ml TPCK-trypsin and incubated for 72 hours. Presence of virus was determined by
hemagglutination assay using 0.5% turkey red blood cells. TCID50 was determined by the ReedMuench method 15.
Inoculation of embryonated eggs with influenza A virus
Embryonated hen eggs from Cackle Hatcheries, Iowa, USA, were inoculated with the
indicated dose of virus in 100uL sterile PBS and 1X egg antibiotics (I need to include these
specifically probably) by needle injection of the allantois cavity. Eggs were incubated at 35°C
for 48 hours, and then chilled overnight. The following day allantois fluid was harvested, cleared
of debris by centrifugation at 1,200 RPM for 5 minutes, stored at -80°C for analysis.
RT-qPCR analysis
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For all experiments 100uL of viral supernatant was harvested in 275uL lysis buffer and
stored at -80C until use. RNA was extracted using the Omega E.Z.N.A. Total RNA I Kit
according to the manufacturer’s instructions and eluted in 50uL RNase-Free Water. 2μL of
total RNA was reverse transcribed with random hexamers using SuperScript III reverse
transcriptase (Invitrogen) according to manufacturer’s instructions. After diluting cDNA 1:10 in
H2O, 4μL was added to a mixture of the indicated primer-probe (IDT), H2O and 10μL of 2x
qPCR MasterMix (TaqMan® Fast Universal PCR Master Mix (2x) Applied Biosystems by Life
Technologies). All qPCR assays were performed using the 7500 Fast system. Cycle-threshold
values were uniformly set to 0.4.
Statistical analysis
Statistical analyses were performed using GraphPad Prism 6.0 software. All statistical
comparisons were performed using One-Way ANOVA with Dunnet’s Correction for multiple
comparisons or Two-Way ANOVA with Sidak Correction for multiple comparisons as indicated
in figure legends.
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3.4 Results
Competitive reverse genetics reveals inherent biases during conditions mimicking
reassortment.
Influenza A virus possesses a segmented RNA genome; as such the coordinated
packaging of each segment must be maintained for progeny virus formation. Each genome
segment must be packaged into newly forming virions to allow replicative success following
egress from the host cell. To assess the potential for reassortment between viruses and
interrogate viral features that dictate selection of a given segment in a competitive context, we
utilized an established in vitro reassortment system. In this system, utilizing an isogenic viral
background, we have identified inherent biases in the creation of reverse genetic derived IAV.
We chose to examine competitive incorporation in the context a common laboratory strain
A/Puerto Rico/08/1934 (H1N1) (PR8H1N1) and compared the results to those we determined
previously for an avian isolate A/shorebird/DE/22/2006 (H7N3) - to examine if the determinants
of reassortment are strain specific. Additionally, we included segments from another avian
isolate – A/mallard/Alberta/144/2007 (H7N9) –and two human strains – A/Memphis/03/2008
(H1N1) (SH1N1) and A/California/04/2009 (H1N1) (PH1N1). In our competitive reverse genetics
system, seven segments are held constant as a stable backbone while five options of the eighth
segment are provided in equal amounts (Figure 3.1 A). The same technique is utilized to
generate wild type and reassortant viruses utilized in later studies. Following a period of
infection the supernatant is harvested, titered, and subjected to a limiting dilution assay to isolate
clonal viruses. Next, individual viruses are isolated, RNA extracted, reverse transcribed,
amplified with segment specific primers and identified by restriction fragment length
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polymorphisms or Sanger Sequencing (Figure 3.1 B). We have assessed the incorporation rate
of Segments 1-3 and 5-8 in at least two independent experiments. Segment 4 (HA) was excluded
from this study due to biosafety concerns.
PR8

H1N1 preferentially packages human-derived genome segments
We found repeatedly that the

PR8

H1N1 background preferentially incorporated segments

derived from human isolates compared to avian origin segments in all cases. More heterogeneity
in resulting viral pools was observed when PA, M, and NS were assessed. We additionally chose
to determine the rescue efficiency of all possible single gene reassortants that may be created
under these conditions. We were able to efficiently recover 22 of 28 viruses to levels within 10fold of the parental PR8H1N1 background (Figure 3.1 B). Only six single reassortant viruses were
not generated after multiple attempts, interestingly including the avian-origin PB2 segments, and
intriguingly the human origin PA segments. Additionally, although we did not assess the
competitive outcomes of Segment 4 (HA) we were able to recover virus representing each of
these as well. We then chose to focus on the genes that comprise the vRNP and polymerase
complexes, as compatibility of proteins derived from these segments have been identified as
primary host restriction factors following reassortment in previous studies.
Preferential Incorporation of Segment 3 (PA) is due replication kinetics in human cells.
We chose to focus on the selection differences of Segment 3 (PA) because of the genetic
interaction of PA and PB2 observed in nature11,12. Prior studies on co-functionality of these
segments identified residues required for function of a H1N1 PA in the context of a H3N2
polymerase complex12. We wondered if similar genetic features determined the differential
incorporation of closely related avian Segment 3 segments in a H1N1 context (Figure 3.1 A). In
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head-to-head competitive transfections in the
PR8

H1N1 segments, only the

PR8

PR8

H1N1 background between the H7N3 and

H1N1 segment was selected (Figure 3.2 A). Conversely, in the

H7N3 context, only H7N3 PA was ever recovered when assessed by limiting dilution assay. We
generated egg-derived stocks of PR8H1N1 and PR8H1N1 7+1 H7N3PA viruses and performed multicycle replication studies at low multiplicity of infection and surprisingly found no difference in
MDCK cells (Figure 3.2 B). Next, we hypothesized there may be differences in coordinated
genome packaging efficiency of these two viruses and utilized a particle-normalized single-step
growth curve to assess the replication efficiency of these viruses in multiple cell types.
Specifically, we included two human cell lines commonly utilized to study influenza viruses.
A549 cells are a human adenocarcinoma cell line that is capable of supporting multi-cycle
replication of IAV. 293T cells are utilized for transfection-based assays, including generation of
reverse genetically-derived IAV, and assessment of IAV polymerase function. As such, we
assessed the virus released from cells infected with equal particle number at 24 hours, in a
single-round infection. As in the low MOI infection in MDCK cells we saw no replication defect
of the PR8H1N1 7+1 H7N3PA relative to PR8H1N1 (Figure 3.2 C). Surprisingly, we saw a multi-log
difference in replication in both human cell lines for

PR8

H1N1 7+1 H7N3PA relative to

PR8

H1N1,

indicating a human-specific blockade of replication of a virus containing only one avian-origin
genome segment. Similarly, we saw a decrease in the production of viral antigen in human, but
not canine cells for H7N3PA relative to PR8H1N1 (Figure 3.2 D).
Identification of Segment 3’s N-terminal region, independent of packaging signals, as a
determinant of selection.
We designed a strain-specific RT-qPCR assay to determine the relative abundance of
viruses in supernatant following transfection and a single blind passage in MDCK cells to
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amplify signal, since there are no replication differences in these cells. We found a greater than
25-fold increase in H1N1PA relative to H7N3PA in the

PR8

H1N1 context and the opposite in the

H7N3 genomic context (Figure 3.3 A).
The terminal regions of vRNA have been identified as determinants of segment
packaging. Nearly a decade ago the identity of numerous synonymous mutations in these UTR
and at the termini of the open reading frames (ORFs) of each segment were shown to impact the
selection of artificial reporter segments encoding the ORF of fluorescent proteins16,17. Increasing
recent evidence points to the central region of genome segments that were not assessed in early
studies as additional critical determinants of selection during competitive conditions between
divergent viruses18,19. To interrogate the contributions of naturally occurring nucleotide variation
across the entire length of the segment we constructed chimeric segments that encode the
packaging region of either PR8H1N1 and the central region of H7N3 or vice versa (Figure 3.3 B).
Additionally, we constructed segments that mimic the boundaries of defective interfering RNAs
that are able to be packaged and propagate during high multiplicity infection, but lack that ability
to produce protein and replicate independently20. We find that in competition with a wild-type
segment bearing the same packaging signals or with the extended DI boundary constructs, that
the central region of the segment is a predominant determinant of segment 3 selection (Figure
3.3 A).
Having excluded traditional packaging signals, we explored whether or not the function
of the polymerase complex in 293T cells was correlated with discrepant genome selection. We
find that in the context of the

PR8

H1N1 polymerase complex H7N3PA is attenuated (Figure 3.3

C). Additionally, the central region of the genome segment is responsible for this defect, as the
packaging signals of DI-like constructs show no difference from the segment in which the central
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region was derived (Figure 3.3 C). To further probe the region necessary for altered polymerase
activity created additional constructs encoding the N- or C-terminus of either strain fused to the
N- or C-terminus of the other strain and a majority H7N3 construct containing only nucleotides
400-700 of

PR8

H1N1 (Figure 3.3 B). We found that the N-terminal region of PR8 (8N3C

construct), located between nucleotides 400-700 (840037008 construct) is sufficient to increase
H7N3PA polymerase function to greater than that of WT-PR8H1N1PA in the context of the
remaining

PR8

H1N1 genome segments (Figure 3.3 C). Together these findings indicate the

central region of Segment 3, between the boundaries of terminal packaging signals, but within
the N-terminal half of the segment likely determines competitive selection.
PA amino acid 184, but not 190, is a context-dependent determinant of differential segment
selection
Having established the central region of segment 3 as the primary segment-intrinsic
driver of selection in this given background, and nucleotides 400-700 as the determinant of
polymerase activity in human cells, we sought to utilize sequence analysis between the three
strains that propagated equivalently but showed divergent selection properties (PR8H1N1, H7N3,
and H7N9). PA of H7N3 and H7N9 contain seven coding changes14. We have previously
investigated the contribution of differences between these viruses as critical to regulation of virus
replication and pathogenesis. H7N3 segment 3 was selected at a much lower rate than that of
H7N9 in the context of a

PR8

H1N1 genome. As such we generated mutant segments bearing

single amino acid changes at three positions that differed most in their biochemical properties
and assessed the contribution of these amino acids to the polymerase activity and competitive
selection of

PR8

H1N1 and H7N3. We generated H7N3PA mutant segments that have the

PR8

H1N1

or H7N9 codons at amino acids 184 and 190, since these are the variable positions in the central
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region of PA we find determines differential polymerase activity (Figure 3.4 A). We generated
each of these viruses as well as a H7N3 PA that has an alternative asparagine codon as a control.
Similarly, we generated a

PR8

H1N1PA construct bearing the amino acids of H7N3PA at position

184. All viruses were able to be rescued in two independent attempts and none of the PA-184variant viruses were attenuated relative to WT- PR8H1N1 (Figure 3.4 B). Both H7N3 PA-P190S
mutants were attenuated in the

PR8

H1N1 genetic background (Figure 3.4 B). We then assessed

the ability of single mutant PA-184-variant segments to function in the polymerase activity
assay. Interestingly, the mutation

PR8

H1N1PA S184N reduced polymerase function by 50% and

H7N3PA N184S had the opposite effect of generating greater than WT- PR8H1N1 activity (Figure
3. 4 C). A silent mutation of H7N3PA N184N did not dramatically alter polymerase activity, and
H7N3PA P190S had no activity restoration effect (Figure 3.4 C).
We then used mutant segments bearing H7N3PA 184-variants in the head-to-head
competition system and assessed relative incorporation compared to the wild-type PR8-H1N1
segment. Interestingly, the N184S mutants drastically increased the H7N3 segment’s
incorporation while P190S and Q400P in the c-terminal region had little effect on selection.
Therefore, we conclude selection of homologous PA segments in competitive reverse genetics
assays in human cells may be due to restriction of PA-184 residues and attenuated polymerase
activity.
Genome constellation present during segment selection impacts the outcome of competitive
experiments.
IAV genome segments have previously been hypothesized to interact with one and other
during assembly although the process through which this occurs remains unclear. Additionally,
myriad viral-viral and viral-host protein interactions may have profound effects on properties of
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each newly generated reassortant virus. Examining the selection outcomes of Segment 3 in the
H7N3 background we found that H7N3 and H7N9 segments were the predominantly selected
strains while

PR8

H1N1 and other human-origin segments were selected infrequently13. Given the

selection disparities between each background we decided to identify the genetic components of
the inherently different selection patterns in the context of whole, replicating virus. To assess
which segments of the genome most directly impact Segment 3’s selection we again utilized a
head-to-head competition approach where in one segment of H7N3 was substituted for the PR8

H1N1 segment and the other six segments were maintained. In this scheme we identified all

segments, save HA and M as capable of altering the selection ratio of

PR8

H1N1PA:H7N3PA

(Figure 3.4 C). PB2 and NA had the most drastic impact on selection, resulting in nearly
equivalent levels of the two segments, though these viruses appears attenuated as the CT-values
for each were lower than in a WT-PR8H1N1 background. These results suggest that the selection
preference of

PR8

H1N1 PA in the

PR8

H1N1 context is likely driven by a required interaction

between PA and one or more viral genes. Additionally, while possible, the co-selection of avian
PA and PB2 seems unlikely given the replication defect observed in this assay.
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3.5 Discussion
Here, we uncovered a previously unappreciated genetic switch that allows certain avianorigin polymerase genes to be incorporated into H1N1 genomes, but prevents others from
reassortment. The selection of a single amino acid variant allows increased incorporation of
H7N3 PA and this is due in part to increased polymerase activity. If segment selection were
unbiased, in the presence of five options, an equal distribution of segment selection would be
expected. The partial conservation of protein function between divergent strains likely allows
rescue of individual reassortant viruses within a reasonable range activity. However, once past a
threshold of packaging efficiency or minimal fitness the resulting reassortant virus will
attenuated or non-functional. Alternatively, differences in protein-protein interactions may lead
to the altered growth of some viruses following reassortment and unequally distributed progeny
virus propulations21. We found that in the case of H7N3 PA, this restriction was not due to
previously characterized genome packaging signals, nor was it due to inherent viral replication
defects in the highly permissive MDCK cell line. Rather, we noted that in the context of a
PR8

H1N1 genetic background, a single amino acid was sufficient to increase polymerase activity

and the likelihood of H7N3 PA segment incorporation into new virions.
The residue we identified, PA-184, has previously been described as an epistatic
regulator of reassortant genome polymerase activity in human cells. In the context of human
H3N2 polymerase, insertion of H1N1 PA yields a functionally dead complex, likely explaining
the recent history of co-assorting of PB2 and PA in human isolates11,12,22. Interestingly, this PA
residue in the context of H3N2 depends on an additional host-restriction residue in PB2 – the
widely studied PB2 627 residue as well as the identity of PA-383 in the same protein12. In a
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crystal structure of the polymerase complex these amino acids reside together spatially within the
vRNP complex to enhance association with a host factor required for replication or efficient
transcription initiation23,24. Additionally, the PA-184 position is required for interaction with the
host factor MCM2, important in processivity of transcription25,26. Finally, PA-184 resides near
the second required nuclear localization signal of PA (186-247)27. Perhaps alteration of the
biochemical properties of PA-184 in the context of some, but not other polymerase complexes
alters the ability of either vRNPs or PA protein itself to be translocated to the nucleus. Together,
our results indicate that the interaction of viral proteins with both host and viral components
determines the outcome of reassortment following co-infection and polymerase activity, along
with similar tropism and efficient genome packaging, are required for segment co-segregation in
newly formed virus particles.
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Figure 3.1. Reassortment potential of an H1N1 virus assessed by competitive transfection
and individual reverse genetic rescue. A. Percentages of each reassortant virus isolated from
culture supernatant of competitive co-transfection assay and limiting dilution assay. Genotyping
was conducted by restriction fragment polymorphism length or Sanger Sequencing. B. Rescue
efficiency of single gene reassortant viruses. Each reassortant virus was rescued twice
independently and titered by TCID50 assay (Geometric Mean +/- S.E.M.).
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Figure 3.2. Genomic context and host cell determines differential segment 3 selection and
virus replication. A. Selection percentage determined by limiting dilution assay of head-to-head
selection experiments in the context of either seven PR8 or seven H7N3 genome segments (n=3
experiments). B. MDCK infection time course. 2x105 cells were plated in 24-well plates and
infected with 250 TCID50 of the indicated virus (Geometric mean +/- S.E.M., performed three
times in duplicate). C. Single cycle replication of PR8 7+1 PA viruses in the indicated cell type.
2x105 cells were plated in 24-well plates and infected at MOI 5 for 24 hours in the absence of
TPCK-trypsin to prevent re-infection. Black bars represent WT-PR8; red bars represent PR8 7+1
H7N3 PA. (Geometric mean +/- S.E.M., performed three times in duplicate). D. Indicated cells
were infected for 8 hours and harvested for flow cytometric analysis of nucleoprotein content.
2x105 cells were plated in 24-well plates and infected at MOI 0.3 for 8 hours. Black bars
represent WT-PR8; red bars represent PR8 7+1 H7N3 PA (Mean +/- S.E.M., performed three
times in duplicate; **, P<0.01).
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Figure 3.3. The central region of segment 3 determines competitive selection and augments
polymerase activity in human cells. A. Schematic of constructs used to assess the location in
segment 3 that confers selection advantage of PR8-PA over H7N3-PA. Black regions indicate
the region of Segment 3 that is derived from PR8-PA and red indicated H7N3-PA derived
regions. B. Relative abundance of primarily PR8-PA or H7N3-PA segment in culture supernatant
following competitive co-transfection and single passage on MDCK cells. Fold-change was
determined with strain-specific TaqMan qPCR probes (N=4-6, mean +/- S.E.M.). C. Polymerase
activity of reassortant polymerase complexes in 293T cells. All values compared to PR8-PA
wild-type segment (N=4-6. mean +/- S.E.M.). All statistical comparisons made by one-way
ANOVA corrected for multiple comparisons relative to PR8-PA WT in the context of the PR8H1N1 genome constelation (****, P<0.001; *, P<0.05).
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Figure 3.4. Identity of PA amino acid 184 and genomic context determines polymerase
function and reassortment potential in human cells. A Polymerase activity of single amino
acid mutant PA polymerase complexes in 293T cells. All values compared to PR8-PA wild-type
segment (N=4-6. mean +/- S.E.M.). All statistical comparisons made by one-way ANOVA
corrected for multiple comparisons relative to PR8-PA WT in the context of the PR8-H1N1
genome constelation (**, P<0.01; *, P<0.05). B. Relative abundance of primarily PR8-PA or
H7N3-PA mutant segments in culture supernatant following competitive co-transfection and
single passage on MDCK cells. Fold-change was determined with strain-specific TaqMan qPCR
probes (N=4-6, mean +/- S.E.M.). C. Relative abundance of PR8-PA or H7N3-PA segments in
culture supernatant following competitive co-transfection and single passage on MDCK cells
when a the indicated H7N3 segment was substituted for the same PR8 segment. Fold-change was
determined with strain-specific TaqMan qPCR probes (N=4-6, mean +/- S.E.M.; (**, P<0.01;
*, P<0.05).
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Chapter 4:
Nucleotide resolution mapping of influenza A
virus nucleoprotein-RNA interactions reveals
the landscape of viral RNA features required
for replication

This chapter has been submitted in its entirety as a research manuscript that is currently in
revision for publication at Nature Communications.
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4.1 Abstract
Influenza A virus nucleoprotein (NP) associates with all eight negative-sense genomic
RNA segments during virus replication. Although the positioning of protein components within
viral ribonucleoprotein complexes (RNPs) is well defined, the native interaction of NP with the
viral RNA (vRNA) and the mechanisms by which a complete multi-segment genome assembles
remain elusive. Here, we applied photoactivatable ribonucleoside enhanced crosslinking and
immunoprecipitation (PAR-CLIP) to assess the native-state of NP-vRNA interactions in infected
human cells. NP bound short fragments of RNA (~12 nucleotides) non-uniformly and without
apparent sequence specificity. Moreover, NP binding was reduced at specific locations within the
viral genome including regions previously identified as required for viral genome segment
packaging. Synonymous, structural mutations in these low-NP binding regions impacted genome
packaging and resulted in virus attenuation, whereas mutagenesis of NP-bound regions had no
effect. Finally, we demonstrate that the sequence conservation of low-NP binding regions is
required in multiple genome segments for propagation of diverse mammalian and avian IAV in
host cells.
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4.2 Introduction
Influenza A virus (IAV) possesses a segmented, negative-sense RNA genome that is
bound by the viral nucleoprotein (NP) throughout replication. The structure of the protein
components within the viral ribonucleoprotein complex (RNP) was recently solved, but the
structure of viral RNA and its interaction with NP have not been elucidated1,2. NP is thought to
coat viral RNA (vRNA) uniformly in cells and virus particles; however uniform coating likely
would preclude the possibility for RNA structure formation in RNPs. Numerous virus families
utilize structured RNA elements for specific biological processes throughout infection, including
genome packaging3,4. For example, viral RNA elements are required for efficient replication,
mRNA splicing, and genome packaging of IAV5–7. Structure formation has been demonstrated
with in vitro folded IAV vRNA and engineered genome segments but the structural constraints
imposed by nucleoprotein on vRNA generated during infection is not known8. Elucidation of the
physiological interaction between NP and viral genomic RNA may provide novel insights into
how IAV is capable of coordinating its lifecycle. Thus, we set out to determine the in vivo
landscape of NP-vRNA interactions.
Infection and complete replication of IAV requires delivery of all eight genome segments
into a recipient cell. All IAV segments require packaging signals derived from the termini on
each segment9,10. Interaction between vRNAs has been demonstrated in vitro and disruption of
packaging signals or interacting segment regions attenuated virus replication at the stage of
genome packaging11–13. In many cases, mutation of a single segment leads to a significant
decrease in the packaging efficiency of other segments5,14. Additionally, viral particles largely
package only one copy of each genome segment15–17. Together, these results suggest that genome
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segments function as a multipartite, cooperatively packaged entity, possibly potentiated by
segment-segment interactions, rather than a stochastically generated particle18,19. In this study, we
set out to determine how IAV NP interacts with vRNA during infection in cells.
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4.3 Results
Nucleotide resolution mapping of NP-vRNA interactions
Photoactivatable ribonucleoside enhanced crosslinking and immunoprecipitation (PARCLIP) coupled to next generation sequencing was used to resolve the interaction between the
negative-sense RNA genome of IAV and NP during infection of human 293T cells20. We
infected human cells with WT-PR8 virus for 16 h in the presence of 4-thiouridine (4-SU) to
enhance crosslinking of NP-RNA complexes and then generated Illumina 1x50 sequencing
libraries of the NP-bound RNA (Figure 4.1 A). The impact of 4-SU on viral replication was
assessed in 293T cells. WT-PR8 replicated to equivalent titers 24 h post-infection (hpi) in mockor 4-SU-treated (100 μM) cells (Figure 4.1 B). Additionally, NP localization after 4-SU
treatment was assessed by confocal microscopy at 16 hpi, and no alteration was observed at this
time point (Figure 4.1 B). These results suggest 4-SU treatment does not substantially impact
IAV protein production or replication in human cells.
To determine the sensitivity and specificity of the PAR-CLIP assay, we performed
Western blotting analysis for IAV NP and cellular ß-actin on input lysate and
immunoprecipitated proteins (Figure 4.1 C, bottom). Compared to immunoprecipitations
performed without antibody or a control anti-HA antibody, immunoprecipitation with a
monoclonal antibody (MAb) against IAV NP produced a specific band. UV-exposure of infected
cells in the presence of 4-SU enabled greater recovery of NP-RNA complexes (Figure 4.1 C,
top). The protein purity in the immunoprecipitate was verified by silver stain or Western blotting
with an anti-IAV polyclonal serum (Figure 4.2 A, B) or IP with a different MAb to IAV-NP
(data not shown).
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Influenza A nucleoprotein minimally binds 11-14 nucleotides per monomer at non-uniform
intervals
PAR-CLIP identified both human and virus-derived RNAs that interacted with NP. The
procedure enriched for IAV RNA sequences relative to RNA-seq libraries (Fig 4.1 D), and the
majority of the viral RNA sequences were derived from the negative-strand vRNA (Figure 4.3).
The average length of the NP-bound vRNA was 12 nucleotides (range 11-14, Figure 4.1 E) and
the distance between high confidence binding events, identified as crosslinking-induced U-to-C
transitions in vRNA sequences, was approximately 25 nucleotides (Figure 4.1 F).
We then compared PAR-CLIP and RNA-seq libraries to identify contiguous regions of
vRNA that are significantly under- and overrepresented among the NP-bound RNAs. Using the
criteria of >3-fold difference, Q<0.01, and ≥18 nucleotides long, we identified 25 regions in the
viral genome that were low in NP binding relative to RNA-seq and 17 regions that met two of
these three criteria that we did not investigate further (Figure 4.4 A-H, Table 4.1). Moreover,
four high-NP binding regions that bound RNA were overrepresented relative to the control
RNA-seq sets (Table 4.1). The low-NP binding regions together represent approximately ten
percent of the viral genome and do not differ in base composition from the remainder of the
genome (Figure 4.1 G). Analysis of low-NP binding regions revealed that RNA secondary
structures might form in the absence of NP binding in some of these regions. Thus, NP binding
might be affected by local secondary structures in the genome of IAV.
Nucleotide identity of low-NP binding regions in Segment 5 vRNA elements is important
for viral replication
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To assess the significance of the over- and underrepresented RNA regions, we selected
six regions in segment 5 that have variable NP-binding profiles (Figure 4.5 A). The lack of
alternative reading frames and splicing and relative conservation of segment 5 compared to other
IAV genome segments made this segment more suitable for extensive characterization. Of these,
two regions were underrepresented (low-NP binding) in PAR-CLIP data sets (NP22-68 and NP14101495

). The NP1410-1495 region contains a previously hypothesized vRNA pseudoknot5. Additional

regions of either NP intermediate binding (NP456-480, NP145-175, and NP1058-1081) or highly bound
vRNA (NP584-608) also were also included in the following studies. Computational prediction of
RNA structures using RNAfold in low-NP binding regions guided further mutational analysis,
and these regions were mutagenized to either disrupt (NP22-68:A and NP1410-1495) or maintain (NP2268:B

) secondary and tertiary structure formation (Figure 4.9). Mutant viruses bearing 2-7

synonymous structural nucleotide changes in these regions were generated and assessed for
ability to replicate in vitro and in vivo.
WT and mutant viruses were subjected to a focus forming assay in MDCK cells to
determine replication competence in vitro (Figure 4.5 B). Mutations disrupting the segment 5
vRNA pseudoknot (NP1410-1495) formation and those predicted to destabilize a stem-loop structure
(NP22-68:A) in the 3’ region of the vRNA segment resulted in reduction of focus area, as a measure
of multi-cycle replication and spread (Figure 4.5 B). Conversely, mutation of intermediate- or
highly-bound vRNA regions did not alter the focus area. Synonymous mutations in NP22-68,
predicted to maintain the secondary structure (NP22-68:B), also did not affect focus size (Figure 4.5
B). Multi-cycle replication assays in MDCK cells of select mutant viruses confirmed these
results (Figure 4.5 C). Finally, mice were inoculated with 103 TCID50 of each virus, and the
presence of infectious virus in the lung was assessed 48 h later. WT-PR8 replicated to high titers
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at this time point whereas destabilizing mutations in low-NP binding regions resulted in
attenuation (Figure 4.5 D). Synonymous structural mutations in intermediate or highly bound
regions had no effect on virus infection in vivo (Figure 4.5 D). These results collectively suggest
that structural features of the low-NP binding regions are important for IAV replication.
To determine the cause of attenuated replication of low-NP binding mutant viruses, we
evaluated effects on specific stages in the IAV lifecycle. All viruses displayed similar
cytoplasmic distribution of NP 8 hpi in MDCK cells when assessed by indirect
immunofluorescence and confocal microscopy (Figure 4.6 A). The ability of the NP proteins
from the mutant viruses to transcribe and replicate a firefly luciferase reporter genome segment
was tested in human cells; all viruses displayed equivalent reporter activity (Figure 4.6 B).
Similarly, infection of MDCK cells with all viruses generated equivalent amounts of viral
antigen (NP) 8 hpi when measured by flow cytometry (Figure 4.6 C). Therefore, the
synonymous mutations introduced within NP segment did not alter NP expression or its activity
by all measurable outcomes.
We next assessed the virus particle to infectious unit ratio of WT and mutant PR8 viruses.
The infectious titer (TCID50/ml) of NP1410-1495 and NP22-68:A mutant viruses was significantly lower
(P<0.05) compared to all other viruses when normalized to HA-units, indicating a greater
production of non-infectious particles (Figure 4.6 D). The ability of WT and mutant viruses to
package all eight genome segments was assessed using a population level measure of relative
vRNA segment abundance in purified viral particles21. RNA from WT and mutant IAVs was
subjected to RT-qPCR and the abundance of segments was normalized to segment 7 (Figure 4.6
E). Mutation of either the predicted pseudoknot (NP1410-1495) or stem-loop structure (NP22-68:A)
resulted in aberrant genome constellation stoichiometry. Consistent with the viral replication
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assays, mutation of intermediate- or highly-bound regions or mutations that maintained the
predicted 3’ stem-loop structure (NP22-68:B) result in unaltered ratios of genome segments in all
but one segment-specific instance (Figure 4.6 and Figure 4.7 A). These results suggest that
RNA structure-destabilizing mutations, in regions of vRNA poorly bound by NP, impact
replication at the stage of coordinated genome packaging. Finally, we determined the coexpression of NP and matrix (M) proteins in singly-infected cells (Figure 4.6 F, multiplicity of
infection (MOI) of 0.05)22. In agreement with the RT-qPCR data suggesting a packaging defect,
a lower percentage of NP1410-1495 and NP22-68:A mutant virus infected cells co-expressed both
proteins compared to cells infected with WT or other mutant viruses. Notably, high MOI
infection with multiple defective particles simultaneously infecting the same cell is able to
overcome this defect (Figure 4.7 B).
Mutation of low-NP binding regions in additional genome segments results in attenuated
viral replication.
Low-NP binding regions in segments 1, 2, and 8 also were evaluated for their
contribution to viral replication by mutagenesis designed to disrupt predicted secondary and
tertiary RNA structures (Figure 4.8 A–C, Table 4.1). Nucleotide substitutions that alter the
predicted RNA secondary structure but have no impact on the protein, i.e. synonymous structural
mutation, in PB21823-1944, PB1497-561 or NS23-86 reduced the focus area of mutant viruses in MDCK
cells (Figure 4.8 D). Similar to the attenuation of segment 5 viruses, the PB21823-1944, PB1497-561 or
NS23-86 mutant viruses generated fewer TCID50 particles per HA-unit (Figure 4.8 E). Segment 1
and 2 mutant viruses did not display altered reporter activity (4.10 A). Additionally, virus
replication in mice was diminished 48 hpi compared to WT-PR8 (Figure 4.8 F). Assessment of
vRNA abundance in virus particles revealed that segment 2 (PB1497-561) mutant viruses packaged
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reduced levels of segment 6 vRNA (NA) (Figure 4.8 G). Manipulation of segment 8 vRNA
sequence (NS23-86) resulted in decreased packaging of segments 3, 4, 5, and 7 relative to segment
1 (Figure 4.8 G). Unexpectedly, the PB21823-1944 virus did not show altered segment abundance
despite the largest in vivo replication defect (Figure 4.8 F and Figure 4.9 C) and difference in
virus particle to infectious unit ratio. Two additional viruses with mutations in this region
(PB21823-1944) also had reduced focus area despite no differences in segment packaging (Figure
4.10 B, C). Together, these data suggest that vRNA sequences that are low in NP binding help to
coordinate packaging of a full complement of eight vRNA segments and changes to the predicted
RNA structures in these regions results in virus attenuation.
Mutation of IAV-PR8 low-NP binding nucleotides attenuates replication of IAV-H7N3 and
IAV-pH1N1
We evaluated the contribution of two low-NP binding regions (PB21823-1944 and NP1410-1495),
identified
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A/California/04/2009 (H1N1) (IAV-pH1N1). The PB2 and NP gene-segment of IAV-PR8 and
IAV-H7N3 are divergent and representative of mammalian and avian viruses, respectively
(Figure 4.11 A, B). The NP gene-segment of IAV-pH1N1 is closely related to IAV-PR8 (Figure
4.11 A), while the PB2 gene-segment is more closely related to avian viruses (Figure 4.11 B).
Isogenic H7N3 and pH1N1 viruses, bearing synonymous mutations in the NP1410-1495 or PB218231944

regions predicted to disrupt local RNA structure, were evaluated for virus replication in vitro.

Synonymous mutations that are predicted to impact RNA secondary structure in these regions of
IAV-H7N3 and IAV-pH1N1 attenuated viral replication, as measured by focus area (Figure 4.11
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C, D). These results indicate that the RNA features, identified by PAR-CLIP in WT-PR8, are
applicable to diverse avian and human strains of IAV.
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4.3 Materials and methods
Cells
Madin-Darby Canine Kidney (MDCK) cells were maintained in minimal essential
medium (MEM) with 5% fetal bovine serum (FBS, Biowest), MEM-vitamins (Gibco), Lglutamine (Gibco), and penicillin-streptomycin (Gibco). Human embryonic kidney cells (293T)
were maintained in Opti-MEM (Life Technologies) with 10% FBS, L-glutamine, and penicillinstreptomycin.
Viruses
Eight bidirectional pHW2000 plasmids containing cDNA for A/Puerto Rico/08/1934
(H1N1), A/California/04/2009 (H1N1), or A/shorebird/Delaware/22/2006 (H7N3) were obtained
from St. Jude Children’s Research Hospital23. Viruses were generated by transfection of all eight
plasmids into co-cultures of 293T and MDCK cells (1 μg per plasmid) with polyethylenimine (8
μg total). Wild-type (herein IAV-PR8 (WT-PR8), IAV-pH1N1 (WT-pH1N1) or IAV-H7N3
(WT-H7N3) and mutant viruses were generated in the same manner with the exception of
substituting individual plasmids harboring mutagenized DNA for the single indicated wild-type
plasmid. The next day, the transfection mixture was removed and replaced with Opti-MEM
containing MEM-vitamins, L-glutamine and penicillin-streptomycin. Forty-eight hours posttransfection, an additional 1 ml of the same media containing 1 μg ml-1 TPCK-Trypsin
(Worthington) was added to the co-culture. Seventy-two hours after addition of TPCK-Trypsin,
culture supernatant was harvested and clarified by centrifugation (5 min, 350 x g). Viral stocks
were generated by infection of MDCK cells in a T75 flask. Cells were washed once with PBS,
and 200 μL of transfection supernatant was mixed with 25 ml of infection media (M0.1B)
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composed of MEM containing vitamins, L-glutamine, penicillin-streptomycin, 0.1% Bovine
Serum Albumin (Gibco) and 1 μg ml-1 TPCK-Trypsin for 48 hours. Stocks were aliquoted and
stored at -80°C until use, and all studies were conducted with passage 1 stocks following
verification of mutant sequence identity. All viruses were generated at least twice independently.
Sequences for primers utilized during mutagenesis of IAV plasmids are available upon request.

IAV Nucleoprotein PAR-CLIP and RNA-seq Library Generation
To identify interactions between viral RNA and IAV nucleoprotein, we adapted the
protocol for PAR-CLIP20 coupled to Next Generation Sequencing to discern nucleotide
resolution maps of protein-RNA interaction across the IAV genome. Confluent 293T cells were
infected at an MOI of 1 for 16 h in the presence of 100 μM 4-thiouridine (4-SU) and then crosslinked with ultraviolet light (310nM, 500,000 μJ total energy). PAR-CLIP was performed
essentially as described before20 with the exception of antibodies used to immunoprecipitate NPRNA complexes: monoclonal antibodies HB65 (ATCC) or MAb8258 (EMD Millipore). Briefly,
protein-RNA complexes were separated on 4-12% SDS-PAGE gels and transferred to
nitrocellulose membranes.
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P-labeled RNA was identified by autoradiography, excised, and

extracted following proteinase K (New England Biolabs (NEB)) digestion. To account for
potential bias introduced during adaptor ligation and sequencing, we also generated RNA-seq
libraries using RNA extracted from uncross-linked cell lysates of influenza infected 293T cells
from which RNA was isolated by TRIzol (Invitrogen) extraction, fragmented by Mg2+ at 95°C
for 12 min (NEB, Magnesium RNA Fragmentation Module).
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P-labeling of this RNA was

performed in solution with T4 PNK (NEB), and size-selection of 10-100 nt fragments by Urea117

Page (15%) was performed. In both cases, total RNA was precipitated with ethanol, and used to
prepare Illumina sequencing libraries. The adaptor sequence contains NNN-degenerate
nucleotides in addition to a sequence used for demultiplexing to facilitate collapsing of
redundantly generated PCR products and ascertain the frequency of individual NP-RNA
interaction events. Following isolation of adaptor ligated and radiolabeled RNA, all subsequent
library generation steps were identical. Independent PAR-CLIP or RNA-seq libraries were
pooled and cDNA synthesized using a primer complementary to the 3’ adaptor (SuperScript III,
Invitrogen). Libraries were amplified by PCR for 9-15 cycles using Phusion DNA polymerase
(Phusion HF Mastermix, Thermo) and primers annealing to the 5’ and 3’ termini of the DNA
that enable flow-cell binding. Size selection of libraries was conducted by extraction of
amplicons from 6% urea gel electrophoresis, and then libraries were precipitated. Molarity of
libraries was determined by qPCR (NEBNext, New England Biosciences) and size by
Bioanalyzer (Agilent). Illumina sequencing on the HiSeq 2500 instrument (1x50bp reads) was
performed by the Genome Technology Access Center at Washington University in St. Louis.

Next Generation Sequencing
All NGS data was analyzed on the Washington University in Saint Louis School of
Medicine’s McDonnell Genome Institute (MGI) cluster using publically available analysis
programs (FastX toolkit, Bowtie, and SAMtools) and in-house scripts20. PAR-CLIP and RNAseq data were generated from four independent experiments. For PAR-CLIP and RNA-seq
libraries we used an analysis pipeline that collapsed unique barcoded reads, removed adaptors,
and aligned them to the viral genome. Strandedness was determined post-alignment and all
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subsequent analysis was performed on negative-sense viral genomic RNA (vRNA). For reads
that mapped to the viral RNAs, we normalized the number of reads per nucleotide to the total
number of reads per genome segment to yield a normalized coverage ratio for both PAR-CLIP
and RNA-seq libraries. We then compared the normalized coverage for each preparation at
nucleotide resolution using an unpaired t-test with False Discovery Rate (FDR) correction
(Benjamini-Hochberg)24. vRNA nucleotides with a FDR minima Q < 0.01 and fold-change >3
were identified and these regions were extended to the final nucleotide of each region where Q ≤
0.1. These areas represent low-NP or high-NP binding regions of interest (ROI). ROI ≥ 18nt
were subjected to RNA structure analysis with mFold, RNAfold, and vsFold5 to determine
computationally the theoretical minimal free energy (ΔG) of each region as well as the potential
secondary or tertiary RNA structure formation25,26. Nucleotide composition of ROIs was
determined by calculating the percent of A, G, C, or U in each region and comparing them to the
percent of each nucleotide in the IAV genome. The approximate periodicity of NP-vRNA
interactions was determined by assessing the nucleotide distance between U-to-C transition sites
in vRNA. UV-crosslinking of 4-SU to IAV NP introduces a U-to-C transition upon reverse
transcription of vRNA due to the residual covalent protein adduct left on the thiouridine base
after proteinase K digestion and RNA recovery. PAR-CLIP data sets were compared to RNA-seq
data sets at each nucleotide position on a per-segment basis and positions using unpaired t-test
with FDR correction as above with a threshold of Q = 0.05. Sites of statistically enriched
transition in PAR-CLIP data sets were tabulated and the sequence distance between these
positions was calculated. Transition events with a step-size of 1, i.e. sequential nucleotides both
with high transition rate, were excluded from analysis because they likely represent single NP-
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RNA interactions of adjacent 4-SU nucleotides in vRNA. Transition rate for four PAR-CLIP
libraries were averaged prior to distance calculation.
Selection, Design, and Generation of IAV Containing Altered RNA structures
Mutant selection was performed after analysis of open reading frames to assess potential
nucleotide degeneracy while retaining coding sequence. Subsequently, we selected five
underrepresented ROIs in four segments (1, 2, 5, and 8) for functional assessment of
manipulating RNA structure on viral replication. We also identified four regions in segment 5,
amenable to extensive silent mutagenesis that were either highly bound or represented at the
same frequency in PAR-CLIP and RNA-seq data sets. We introduced between 2 and 7
synonymous mutations simultaneously in silico to the identified regions and reassessed structural
stability or pseudoknot formation using the same structure prediction programs. We selected
variant codon combinations that would disrupt or maintain the predicted vRNA structure but not
change the encoded amino acid, alter codon usage, or disrupt alternative reading frames or
splicing events. Once predicted destabilizing mutations were identified, mutant viruses were
generated. Mutations were introduced into pHW2000 bidirectional plasmids by inverse PCR
with primers including selected mutations and unique ligation sites. PCR products were gel
extracted and digested with either BsmbI (New England Biolabs, (NEB)) or AarI (Thermo Fisher
Scientific) restriction enzymes and DpnI (NEB) to remove residual parent plasmid. Digested
PCR products were PCR purified and ligated using Instant Sticky End Ligase (NEB). Ligation
products were transformed into E. coli, plated on selective LB Agar. Colonies were selected and
grown overnight in LB broth and selective antibiotics. All plasmids were grown in 200 ml LB
Broth prior to preparation by Qiagen HiSpeed Endotoxin-Free MaxiPrep and verified by Sanger
Sequencing (Genewiz).
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Influenza A Virus Focus Forming Assay
Six-well plates of MDCK cells were plated and inoculated with 1 ml of 10-fold serially
diluted virus stock for 1 h in M0.1B. After 1h, the inoculum was removed, and replaced with an
overlay of 1% Low Melting Point Agarose in MEM supplemented with 1 μg ml-1 TPCK-Trypsin.
Seventy-two hours post infection cells were fixed in 5% formaldehyde, permeabilized with 0.1%
saponin in HBSS, and stained for NP protein with biotinylated anti-NP (mAB8258b, Millipore).
Foci were visualized by addition of HRP-conjugated streptavidin and TruBlue streptavidin
substrate and imaged on a Biospot reader (Cellular Technology Limited). Individual foci were
counted and area was calculated using the Analyze Particles extension within Fiji27. The area of
the foci formed by mutant viruses was normalized to the average of WT-PR8 foci per
experiment. A minimum of 60 foci was analyzed per virus.
Confocal Microscopy
We infected 293T cells in the presence or absence (mock) of 4-SU with WT-PR8 (MOI
of 1) for 16 h. Briefly, 293T cells were seeded on glass coverslips coated with poly-D lysine
overnight. Cells were infected with WT-PR8 for 16 h then fixed with 4% methanol-free PFA in
PBS (pH 7.4), washed with PBS, permeabilized with saponin, then NP staining was performed
using anti-NP MAb HB65 and goat-anti-mouse Alexa-488 (Invitrogen). Nuclei were
counterstained with DAPI. Coverslips were mounted to slides with ProLong® Diamond Antifade
Mountant (Molecular Probes). To determine if viral protein production was impacted by
synonymous mutations, we utilized confocal microscopy to visualize the distribution of NP
during infection as a marker of viral protein production and a proxy for trafficking of vRNPs.
MDCK cells were infected with WT-PR8 and indicated mutant viruses (MOI of 0.2) for 8 h then
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fixed and permeabilized as before. NP staining was performed as above using anti IAV-NP MAb
HB65 and Goat-anti-Mouse Alexa-488 (Invitrogen). Slides were imaged with Zeiss LSM 880
Confocal Laser Scanning Microscopy with Airyscan and analyzed with Zeiss Zen Black
Software performed within the Molecular Microbiology Imaging Facility at Washington
University in Saint Louis.
Influenza A virus Reporter Assay
To assess the impact of silent mutations on polymerase complex activity, pHW2000
plasmids encoding WT or mutant PB2, PB1, PA, and NP were utilized in a dual-luciferase
reporter assay as previously described23. A vRNA-like firefly luciferase reporter plasmid and a
Renilla luciferase expression plasmid also were included. Briefly, 293T cells were seeded into
24-well plates and transfected with equal amounts of all six plasmids (500ng DNA total) in OptiMEM containing TransIT-LT1 (Mirus). Cells were maintained at 37°C for the duration of the
experiment. Forty-eight hours later, cells were lysed for analysis of luciferase activities
(Promega). Each combination of polymerase proteins (set of plasmids) was examined in
duplicate. The relative light units (RLU) of firefly luciferase activity were normalized to the
RLU for Renilla luciferase activity within the same sample to account for differences in
transfection efficiency between wells and experiments. The activity of each plasmid set
containing a mutant segment was normalized to the activity of WT-PR8.
Flow Cytometry
To determine the amount of NP generated at a fixed time during infection, we infected 2
x 105 MDCK cells (MOI of 0.2). Eight hours post-infection, cells were harvested and fixed.
Intracellular staining of IAV antigen was performed as above using an anti-IAV NP primary
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antibody (HB65) and an Alexa-488-conjugate goat-anti-mouse secondary antibody (Invitrogen).
The mean fluorescence intensity (MFI) of NP+ cells was plotted and calculated from two
experiments performed in duplicate. Co-expression of NP and M in MDCK cells was determined
16 hpi with an MOI of 5 and 0.05. Infected cells were fixed and stained as above with the
additional staining step of utilizing mouse-anti-M primary antibody (M2-1C6) and goat-antimouse Alexa-647 secondary. A second intracellular staining step utilizing biotinylated mouseanti-NP (mAb8258b) and Alexa-488 conjugated streptavidin was then performed. The frequency
of co-expression was calculated by determining the number of cells expressing NP or M as well
as those expressing both. The percentage of infected cells co-expressing NP and M was
calculated by dividing co-expressing cells by all cells expressing one or more viral protein as
previously described22. Analysis of viral proteins was determined using a flow cytometer and
FlowJo software (Tree Star).
Multi-step Replication of Influenza A virus
MDCK cells (2 x 105) were seeded in 24-well plates and inoculated the next day with 200
TCID50 of IAV. Cells were washed once with PBS before addition of inoculum in M0.1B and
incubated for 1 h at 37°C. Subsequently, the cells were washed twice with PBS and 1 ml of
M0.1B supplemented with 1 μg ml-1 TPCK-Trypsin was added to each well. Culture
supernatants were collected at 24 and 48 hpi and the amount of infectious virus was quantified
by titration on MDCK cells.
Titration of Influenza A virus (TCID50)
Confluent monolayers of MDCK cells were grown overnight in 96-well tissue culture
plates. The next day the cells were washed with PBS and inoculated with ten-fold serial dilutions
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of culture supernatant or lung homogenate for one hour in M0.1B at 37°C. After 1 h the
inoculum was removed and replaced with M0.1B supplemented with 1μg ml-1 TPCK-Trypsin
and incubated for 72 hours. Presence of virus was determined by hemagglutination assay using
0.5% turkey red blood cells. TCID50 was determined by the Reed-Muench method28.
Infection of mice with influenza viruses
Male C57BL/6J mice (5 to 6 weeks of age) were bred in-house in a barrier facility at
Washington University School of Medicine, St. Louis, MO or purchased from Jackson
Laboratories. Mice received food and water ad libitum and all experiments were conducted in
accordance with rules of the Institutional Animal Care and Use Committee. Mice were
anesthetized with isoflurane in an airflow chamber and then inoculated intranasally with 30 μL
of sterile PBS containing 1,000 TCID50 of WT-PR8 or the indicated mutant virus. Forty-eight
hours post-infection, lungs were harvested and homogenized in 1ml M0.1B, cleared by
centrifugation at 1,200 x g for 5 minutes, then stored in aliquots at -80°C. Viral titers from lung
homogenates were determined by TCID50 assay.
Segment Abundance RT-qPCR
MDCK cell derived stocks of WT-PR8 or mutant viruses were clarified by centrifugation
at 1,200 x g for 5 min, passed through a 0.22 µM filter, and pelleted on 30% sucrose cushion by
ultracentrifugation (Beckman SW32ti swinging bucket rotor, 27K RPM, 4°C for 90min).
Pelleted virus particles were directly resuspended in 350 μL TRK lysis buffer, and RNA purified
immediately and eluted in 30 μL DEPC H2O (Total RNA Kit I, Omega). cDNA was synthesized
from 5µL of RNA with SSIII Reverse transcriptase (Invitrogen) and a vRNA specific primer21.
Total cDNA was diluted 1:10,000 and used to quantify each of the 8 genome segments by SYBR
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Green qPCR (PowerUpTM SYBR® Green Master Mix) with primer pairs previously published.
Relative abundance of each genome segment was calculated as before, except with normalization
to Segment 1 or 7 depending on the virus assessed.
Statistical Analysis
All statistical analysis was performed using GraphPad Prism 7.0. For comparison of
PAR-CLIP and RNA-seq data sets, we used multiple unpaired t-tests with the BenjaminiHochberg correction to identify areas in which these sequencing preparations were statistically
different from each other (Q < 0.1 and Q < 0.01). Transition-distance was determined using FDR
(Q < 0.05). For analysis of the focus forming assay, luciferase assay, and lung viral titers we
used one-way ANOVA with multiple comparison corrections (Kruskal-Wallis test). TCID50 per
HA-unit was analyzed using an unpaired t-test.
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4.5 Discussion
We have identified the interaction landscape of IAV NP with viral RNA in the context of
infected cells. Our findings indicate that binding of NP to viral RNA is restricted to an average of
12 nucleotides and the distance between two crosslinking sites is 25 nucleotides. These estimates
agree with molecular models of NP-RNA interactions and the NP-binding footprint of a related
orthomyxovirus1,19,29,30. Within this model, NP is excluded from consistent interaction with
specific regions of vRNA and allows trans-interactions with either other genome segment vRNA
or host and virus factors. The interaction between NP and the viral RNA was non-uniform and
characterized by regions that were consistently low- or high in NP binding. More than half of the
low-NP regions have potential to form secondary and tertiary RNA structures, based on
computational analysis, and mutations that are predicted to alter the stability of these RNA
structures resulted in attenuated virus infection (summarized in Table 4.2). The presence of
RNA structures in RNP complexes may explain the pleomorphic nature of RNPs31. Several,
mostly shorter low-NP binding regions were not predicted to form stable structures. These
regions may represent a portion of a larger RNA structure or have a yet unknown function during
IAV replication to the fact that they are consisted of shorter sequences, had no detectable impact.
These regions may represent a portion of a larger but less stable structure or have a different yet
unknown function during IAV replication. We examined NP-vRNA interactions at a late time
point when a majority of viral RNA is distributed throughout the cytoplasm and thought to be
within vRNP complexes. In support of this, the great majority of PAR-CLIP reads were obtained
from negative sense vRNAs.
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We found many low-NP binding RNA regions that overlap with previously predicted
packaging and bundling signals near segment termini (NP22-68, NP1410-1495, and NS23-88)5,32.
However, additional low-NP binding regions were identified throughout the segment body and
outside of traditional packaging singals10,21,33. Our findings agree with studies assessing structureguided mutagenesis of hypothetical vRNA structures (segment 7) or biochemical analyses of
vRNA (segment 8) that largely overlap with low-NP binding regions assessed here7,34.
Additionally, we identified specific nucleotides required for co-packaging of segment 2 (PB1)
and segment 6 (NA), in a region recently implicated in directing reassortment outcomes and cosegregation of these segments in vitro35,36. Therefore, NP PAR-CLIP allowed us to directly
identify potentially functional RNA regions in IAV genomes required for coordinated genome
packaging.
As predicted RNA structures in the low-NP binding regions are important for genome
packaging, it suggests a requirement for inter-segment RNA interactions. Specific RNA
interactions between genome segments have been demonstrated in vitro and ablation of these
interactions lead to aberrant genome packaging; an outcome reversed by introduction of
compensatory mutations in the interacting segment11. Many of the mutations that alter genome
assembly also lead to an increase in number of defective viral particles32. The formation and
nature of vRNA structures is likely contingent on the sequence composition and physical
position of the nucleotides within a RNP complex.
IAVs can reassort and generate novel and potential pandemic strains. We tested if the
regions identified in IAV-PR8 were required for replication of a divergent H7N3 virus.
Synonymous structural changes in the same vRNA regions of two separate segments in both
IAV-H7N3 and IAV-pH1N1 were attenuating and suggest conservations of these structural
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elements. Future examination of NP-binding of viral RNA in diverse strains of IAV is likely to
identify overlapping and distinct high and low-NP binding regions. These RNA features may be
required for all viruses as coordinating packaging elements, but additional regions act as strain or
lineage specific packaging enhancers. Further, these strain or lineage specific RNA features,
required for genome packaging, may act as potential determinants of reassortment outcomes.
Prior experimental systems demonstrated that co-segregation of genome segments occurs during
natural reassortment as well as lab-adaptation of virus strains to create new vaccines23,36. Finally,
attenuation of genome packaging through silent, structural mutations has the potential to
accelerate live attenuated vaccine production using native genome constellations to allow
vaccination with all protein epitopes of a novel pandemic virus, without the need for master
donor strains.
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Figure 4.1. Development of PAR-CLIP for IAV NP
a, Schematic for IAV NP PAR-CLIP assay. b, Effects of 4-SU (100 μM) on attenuate IAV
replication was assessed by TCID50 assay (bottom) or confocal microscopy (top).
Immunofluorescence staining for NP (green) was assessed in the presence or absence of 4-SU
and counterstained with DAPI to identify cellular nuclei (blue). c, PAR-CLIP was conducted on
293T cells infected with WT-PR8 in the absence (lanes 1 and 2) or presence of a monoclonal
antibody against to IAV NP (lanes 3-6) or viral hemagglutinin protein (HA) (lanes 7-8). The
effect of UV cross-linking on binding of RNA to the viral NP is shown in lanes 3-4 (no UV) and
lanes 5-6 (with UV). Radioactivity (32P) is visualized by autoradiograph and the presence of
absence of NP and cellular ß-actin was done by western blot. The input sample and eluate are
loaded in the uneven and even lanes respectively. The results are representative of four
independent experiments. d, Proportion of PAR-CLIP or RNA-seq derived reads mapping to
human or IAV genomes (**, P < 0.01, n = 4). e, Length of negative-sense viral RNA (vRNA)
aligning reads was determined using FastX Toolkit and the number of reads of a certain length is
plotted as a proportion of total vRNA mapping reads. Mean (black line) +/- S.E.M. (blue
shading) of 4 experiments. f, Nucleotide distance between crosslinking-induced A-to-G
transitions in vRNA mapped PAR-CLIP data (mean + S.E.M. of 4 experiments). g, Nucleotide
composition of low-NP binding

regions and IAV genome (displayed as average base

composition of all eight gene-segments) . No significant differences were detected between
groups.
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Figure 4.2. NP immunoprecipitation protocol results in pure NP elution. a, Silver stain of
immunoprecipitation (IP) eluate for IAV infected cells with either anti-HA or anti-NP antibodies.
The upper band represents NP and lower band represents IgG heavy chain. Gel image is
representative of two independently performed experiments b, IP of NP from purified virus
particles removes all other viral proteins. Western blot using polyclonal goat sera against H1N1
virus to detect all viral proteins in input and NP-immunoprecipitated eluate. Lane 1 is a marker,
lanes 2 and 3 are control immunoprecipitation beads in which no virus lysate was added. Lanes 4
and 5 are input or IP eluate from virus lysate immunoprecipitated with anti-NP antibody HB65.
The membrane was probed with goat-anti-IAV USSR (H1N1) (US Biological, I7650-78B) and
IRDye 800CW donkey-anti-goat (Licor). Gel image is representative of two independently
performed experiments.
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Figure 4.3. NP binds negative-strand IAV genome and immunoprecipitated RNAs are
representative of total cellular IAV RNA levels. Percentage of mapped reads derived from
negative-sense viral RNA (vRNA) for four PAR-CLIP experiments (mean + S.E.M., n = 4) and
PAR-CLIP and RNA-seq sequence abundance per gene segment (vRNA only) of IAV.
Calculated as the total number of base calls per segment and normalized to segment 1 (mean +
S.E.M., n = 4 each).
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Figure 4.4. Nucleoprotein binding is non-uniform in all eight IAV genome segments. a-h,
Normalized coverage for complete genome segments for PAR-CLIP (red) and RNA-seq (black).
Lines represent mean +/- S.E.M from four experiments each.
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Figure 4.5. Manipulation of vRNA in low-NP binding regions that disrupts predicted RNA
structure attenuates virus replication
a, Normalized coverage +/- S.E.M was determined for each nucleotide in the PAR-CLIP (red
symbols) and RNA-seq (black symbols) libraries (n = 4 each). Six regions of interest (ROI) in
segment 5 (NP) are highlighted including two low-NP binding regions (NP1410-1495 and NP22-68),
one high-NP binding region (NP584-608) and three intermediate NP-binding regions (NP145-175,
NP456-490, and NP1058-1081). Each ROI is indicated with a colored bar. b, Focus area of WT-PR8
and NP mutant IAV. MDCK cells were infected with serial dilutions of the indicated viruses and
overlayed with infection media (M0.1B) containing 1% agarose and TPCK-trypsin. Seventy-two
hours later cells were fixed, permeabilized, and stained for viral antigen (NP). Focus diameter
was determined and normalized to WT-PR8 per experiment. Results are the average + S.E.M. of
3-5 experiments per virus (> 60 foci each). c, MDCK cells were infected with MOI=0.001 of the
indicated viruses and culture supernatant was collected at indicated time points then titered on
MDCK cells. Results are the average +/- S.E.M. TCID50/ml of two experiments performed in
duplicate. d, C57BL/6J mice were inoculated with 103 TCID50 of the indicated viruses in 30µL.
Lungs were collected, homogenized, and titered on MDCK cells. Each dot is a single mouse and
the line is the geometric mean. Dotted line in c and d represents the limit of detection. (***, P <
0.005; **, P < 0.01; *, P < 0.05; n.s., not significant)
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Figure 4.6. Attenuating mutations in segment 5 impact coordinated genome packaging
a, Confocal microscopy images depicting the localization of nucleoprotein (NP) eight hours post
infection (hpi). MDCK cells were infected with the indicated virus (white text), and NP was
identified using the MAb HB65 and Alexa-488 conjugated goat-anti-mouse secondary antibody
by immunofluorescence. Cell nuclei are counterstained with DAPI. Panels depict the merged
image of DAPI and NP staining. Fields are representative of two independent experiments. b,
Dual-luciferase reporter assay to assess viral transcription and genome replication, each
combination of plasmids was assessed 3-5 times with corresponding the WT-PR8 combination.
c, Mean fluorescence intensity (MFI) of NP in virally infected MDCK cells (MOI = 0.05,
experiments were performed twice in duplicate) as revealed by flow cytometry. d, Viral titer
(TCID50/ml) of 4 HA-units of WT-PR8 and mutant viruses. Results are the average of three viral
titrations and two HA assays per infectious virus titration (TCID50 assay and HA titration
experiments, average MFI + S.E.M). e, Proportion of infected cells co-expressing of matrix (M)
and NP proteins in singly infected MDCK cells (MOI = 0.05) 16 hpi as revealed by flow
cytometry. The average percentage of co-expression was calculated from two experiments
performed in duplicate. f, Relative abundance of genome segments in purified WT or mutant
viruses. All segments were compared to segment 7 (M) vRNA and normalized to the average of
WT-PR8 values using the 2-ddCt method55. Bars represent the mean of 3-6 independent virus
preparations + S.E.M. (*, P < 0.05; n.s., not significant)

143

Figure 4.7. Additional mutations in NP-bound regions have minimal effect on coordinated
genome packaging and decreases in viral protein co-expression may be overcome by high
multiplicity of infection. a, Packaging qPCR of additional mutant viruses, as in Figure 3f (*, P
< 0.05). The relative abundance of each genome segment in concentrated virus particles was
assessed and normalized to Segment 7 and WT-PR8 virus by the 2-ddCT method as stated in the
materials and methods. b, co-expression of M and NP proteins in MDCK cells infected at high
MOI (5) for 16 hours. High MOI infection of MDCK cells overcomes co-expression defects
observed at low MOI (Figure 3e). Proportion of infected cells co-expressing of NP and M was
determined by calculating the number of NP+M+ double positive cells and dividing by the total
number of cells expressing NP or M when assessed by flow cytometry. Results are derived from
two independent experiments performed in duplicate.
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Figure 4.8. Synonymous structural mutations in low-NP binding regions in Segments 1, 2,
and 8 attenuated virus replication and genome packaging.
a-c, Segment 1 (a, blue line), 2 (b, grey line), and 8 (c, green line) low-NP binding regions
defined by PAR-CLIP analysis. Normalized coverage +/- S.E.M was determined for each
nucleotide in the PAR-CLIP (blue, grey or green symbols) and RNA-seq (black symbols)
libraries (n=4 each). d, Relative focus area of WT-PR8 and segment 1, 2, and 8 mutant viruses.
Bars are the average + S.E.M. of 3 experiments per virus (> 60 foci each). e, Viral titer
(TCID50/ml) of 4 HA-units of WT-PR8 and mutant virus. Results are the average of three viral
titrations and two HA assays per infectious virus titration (TCID50 assay and HA titration
experiments, average MFI + S.E.M). f, C57BL/6J mice were inoculated with 103 TCID50 in
30µL. Lungs were collected 48 hpi, homogenized, and titered. Each dot is a single mouse and the
line is the geometric mean. Dotted line in f represents the limit of detection. e, Relative
abundance of genome segments in purified WT or mutant viruses. All segments were compared
to segment 1 (PB2) vRNA and normalized to the average of WT-PR8 values using the 2-ddCt
method55. Bars represent the mean of 3-6 independent virus preparations + S.E.M. (***, P <
0.005; **, P < 0.01; *, P < 0.05; n.s., not significant).

146

Figure 4.9. Predicted RNA structure of WT-PR8 and the indicated mutant viruses. In all
cases the nucleotides substituted are highlighted and WT-PR8 structures are to the left of the
arrow. a, alteration of a previously identified pseudoknot within the NP1410-1495 vRNA region.
Alteration of predicted secondary structures in the indicated vRNA regions for NP22-68 region
(b), PB1497-561 (c), NS23-88 (d). and PB21823-1944 (e).
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Figure 4. 10. Multiple mutations in Segment 1 unbound region attenuate focus formation
but do not lead to apparent segment-specific packaging defects. a, Dual-luciferase reporter
assay to assess viral transcription and genome replication, no significant differences observed
(average + S.E.M. of three experiments performed in duplicate). b, Relative focus area of WTPR8 and segment 1 mutant viruses (n=3 experiments per virus, area for > 40 total foci per virus
calculated). c, Relative abundance of genome segments in purified WT or mutant viruses. all
segments were compared to segment 1 (PB2) vRNA and normalized to the average of WT-PR8
values using the 2-ddCt method55. Bars represent the mean of 3-6 independent virus preparations +
S.E.M. (***, P < 0.005; **, P < 0.01; *, P < 0.05; n.s., not significant).
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Figure 4.11. vRNA regions required for PR8 replication are required for replication of
contemporary avian and human IAV.
a, Phylogenetic analysis of segment 5. WT-PR8, WT-H7N3, or WT-pH1N1 IAV are indicated
by corresponding, labeled arrows. Phylogenies were created from randomly sampled full-length
segment 5 sequences downloaded from NCBI IVR. Alignment performed in MEGA (version 7)
using MUSCLE. Phylogenetic trees created using the Maximum Parsimony method included in
MEGA. Phylogenies were visualized in FigTree and manually annotated. Green shading
represents segment sequences derived from avian viruses; red represents human viruses; and blue
represents swine viruses. b, Phylogenetic analysis of segment 2 performed as in (a). c, Relative
focus area of WT-H7N3 and mutant viruses + S.E.M. d, Relative focus area of WT-pH1N1 and
mutant viruses + S.E.M. ****, P < 0.001; 3 experiments, > 60 foci per virus with three
independent experiments performed per virus.
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Segment 1
Low (nt)

FDR min

Foldchange

Length

High (nt)

FDR min

Foldchange

Length

307-333*

0.01

>3

>18

117-150

0.01

<3

>18

408-431

0.05

>3

>18

2141-2159

0.05

>3

>18

1089-1121

0.05

>3

>18

1823-1944*

0.01

>3

>18

2321-2341

0.05

>3

>18

FDR min

Foldchange

Length

Segment 2
Low (nt)

FDR min

Foldchange

Length

297-419*

0.01

>3

>18

39-56*

0.01

>3

>18

465-482

0.01

<3

>18

2178-2195

0.01

<3

>18

497-561*

0.01

>3

>18

930-955*

0.01

>3

>18

1294-1314

0.05

>3

>18

1423-1440*

0.01

>3

>18

1521-1576

0.05

>3

>18

1746-1773*

0.01

>3

>18

1790-1817*

0.01

>3

>18

High (nt)

Segment 3
FDR min

Foldchange

Length

619-640

0.05

>3

>18

792-817

0.05

>3

>18

1098-1113

0.01

>3

16

Low (nt)
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Segment 4
Low (nt)

FDR min

Foldchange

Length

Low (nt)

FDR min

Foldchange

Length

208-240*

0.01

>3

>18

98-151*

0.01

>3

>18

252-282

0.05

>3

>18

980-1009

0.05

>3

>18

376-430*

0.01

>3

>18

1446-1463

0.01

<3

>18

441-464

0.05

>3

>18

491-528

0.05

>3

>18

602-628

0.05

>3

>18

1256-1340*

0.01

>3

>18

1585-1661*

0.01

>3

>18

1719-1770*

0.01

>3

>18

Segment 5
Low (nt)

FDR min

Foldchange

Length

High (nt)

FDR min

Foldchange

Length

22-68*

0.01

>3

>18

634-661

0.01

<2

>18

261-329

0.01

>3

>18

766-787*

0.01

>3

>18

337-378

0.01

>3

>18

1410-1495*

0.01

>3

>18

1514-1560*

0.01

>3

>18

Segment 6
Low (nt)

FDR min

Fold

Length

High (nt)

FDR min

Fold

Length

249-269*

0.01

>3

>18

1181-1199

0.05

>3

>18

849-866

0.05

>3

>18

1038-1057*

0.01

>3

>18
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1080-1197

0.05

>3

>18

Segment 7
Low (nt)

FDR min

Fold

Length

High (nt)

FDR min

Fold

Length

1-16

0.01

>5

16

601-632*

0.01

>3

>18

142-201*

0.01

>3

>18

640-660*

0.01

>3

>18

839-866

0.05

>3

>18

Segment 8
Low (nt)

FDR min

Fold

Length

High (nt)

FDR min

Fold

Length

23-86*

0.01

>3

>18

413-430

0.05

>3

>18

113-139

0.05

>3

>18

867-885*

0.01

>3

>18

Table 4.1. Low- and High-NP bound regions of vRNA.
Regions of vRNA greater than or equal to 18 nucleotides long and meeting criteria described in
the methods. NP-low indicates the region was significantly lower in PAR-CLIP than RNA-seq
and NP-high indicates the region was significantly higher in PAR-CLIP than RNA-seq. FDR
Minima is the minimum False Discovery Rate for each region. Fold-change is absolute folddifference between PAR-CLIP and RNA-seq data. The regions that meet all three criteria are
denoted with asterisks, while those meeting two are not.
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Virus

NP
22-68:A

NP
22-68:B

NP
145-175

NP
456-490

NP
584-608

NP
1058-1081

NP
1410-1495

PB2
1823-1944

PB1

497-561

NS
23-88

Effects on Virus

NPbound

WT
–ΔG
(MFE)

Effect of
Mutations

--

-8.7

--

Focus
Size

Lung
Titer

HA:TCID50
Ratio

Segment
Packaging

H7N3
and
pH1N1
Shared

ê–ΔG

êê

ê

êê

êê

N.D.

-8.7

No effect

=

=

=

=

N.D.

=

-8.0

ê–ΔG

=

=

=

=

N.D.

=

-3.2

No effect

=

=

=

=

N.D.

++

-0.0

No effect

=

=

=

=

N.D.

=

-0.0

No effect

=

=

=

=

N.D.

--

-19.8

Modified
Pseudoknot

êê

êê

êê

êê

++

--

-33.0

Modified
Pseudoknot

ê

êê

êê

êê

++

--

-12.9

ê –ΔG

ê

ê

êê

êê

N.D.

--

-10.0

Modified
Pseudoknot

êê

ê

êê

êê

N.D.
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Table 4.2. Disruption of potential RNA structural elements contributes to virus
attenuation.
For NP-binding the following categories were considered: --, significantly lower that WT-PR8;
=, equal to WT-PR8; ++, greater than WT-PR8. The regional stability was determined in WTPR8 and mutant virus using Vienna RNAfold. MFE: minimum free energy. All calculations were
performed using the default settings without imposing structural constraints. Pseudoknot
formation potential was performed using vsFold5 and default settings. Results for focus area,
lung

titer,

TCID50/ml:HA ratio,

relative

segment

packaging

and

conservation

in

A/shorebird/Delaware/22/2006 (H7N3) are summarized from previous figures (=, equivalent to
WT-PR8; ê, P < 0.05; êê, P < 0.01).
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Chapter 5:
Conclusions and Future Directions
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5.1

Production and packaging of eight segments complicates IAV evolution
Influenza A viruses (IAV) possess eight genome segments that must be co-packaged into

nascent virions to enable fully productive subsequent infection1. Throughout prior chapters, I
have discussed the individual components of IAV genome packaging, reassortment, and how
congruence between viral factors, RNA and protein, are required for generation of genetically
diverse infectious virus, propagation, and pathogenesis. Herein, I will discuss the layers of
genetic compatibility we found to be a pretext for the potential of reassortment, as well as
unresolved and newly generated questions which future studies may be directed towards.

5.2

Environmental and cellular requirements for reassortment
The potential for pandemic formation of antigenically novel viruses necessitates

simultaneous replication of parent viruses in a single host cell2. For contemporaneous cellular
infection to occur a singular virus must have the ability to infect a host via either the respiratory
(in mammals) or oral-fecal (in birds) route, establish replication, and spread within the target
tissue. Additionally, once a singular virus has infected and established replication, the secondary
virus must co-infect the host and disseminate to a shared site of replication. Recent studies
demonstrate that tissue localized co-infection must be relatively contemporaneous, otherwise the
host innate immune system likely suppresses the chances for super-infection2,3. The speed of coinfection on an organismal level has not been exhaustively studied, but the cellular time scale has
been assessed in vitro3. In Chapters 2 and 4, I explored a method to bypass the required cellular
co-infection by utilizing an in vitro co-transfection protocol4. By so doing, we minimized
temporal and spatial issues related to co-infection. The results from those reassortment screens
demonstrated that genetic as well as host factors are important determinants of what potential
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new viruses may emerge. Subsequent sections of this chapter will focus on these findings and
expound upon implications for viral evolution.

5.3

Reassortment may augment the fitness of viral quasispecies to overcome
replication and transmission bottlenecks.
Segmentation, while complicating genome packaging, increases the potential for

exploration of sequence space within and between multiple hosts following reassortment5,6.
Influenza viruses have an error prone polymerase (PB1), generating 5x10-5 mutations per
genome segment copied, therefore each new virus genome may contain 2 or 3 de novo
mutations7,8. As such, the potential for acquisition of both beneficial and deleterious mutations at
the RNA or protein level are possible. Recent studies on viral quasispecies demonstrate that
variations in the mutation rate itself can be deleterious to viral fitness7,9. However, if a mutation
is acquired in one segment, this allows transfer of evolved genetic information to a new genome
constellation. In the case of beneficial mutations, such as those that overcome species-specific
restriction factors, acquisition of a segment bearing this signature may enable host range
diversification5. Conversely, if a deleterious mutation is acquired, it may be rapidly purged from
the quasispecies with little consequence to the population at large. Additionally, the rapid withinhost divergence likely alters the between host transmission potential, as this is both a physical
and genetic bottleneck, especially when zoonosis occurs10. This has been demonstrated
experimentally by sequencing viral populations at the site of infection in one host as well as the
recipient in which a narrowing of genetic diversity has occurred within and between host
quasispecies11. Co-infection presents many logistical issues during viral replication. Replication
complexes comprised of heterogeneous polymerase subunits derived from either virus likely
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form, potentially altering the copy number of certain segments. It is unknown if heterogeneous
polymerase complexes faithfully replicate genome segments to the same extent as a homogenous
complex; if not, the rate of spurious mutations may increase during the initial and subsequent
rounds of infection following the original co-infection event and increasing again the diversity of
a quasispecies. Similarly, when the mutation rate is enhanced, or a large proportion of genome
segments are defective, reassortment between strains may be enhanced12.

Figure 5.1. IAV co-infection may produce progeny viruses that possess mixed
genomes through reassortment. When two parent viruses co-infect a cell (left), prior
to the initiation of genome replication (right), generation of progeny IAV containing
different combinations of genome segments (256 possible combinations) may occur. In
addition to reassortment, or acquisiton of a new genome constellation component, the
error prone polymerase of IAV may introduce mutations to genome segments during
replication that alter the fitness of viruses in which they are packaged.
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5.4

Decoding reassortment potential
Numerous studies demonstrate that protein compatibility is not the sole driver of

reassortment potential despite critical interactions required for replication13–16. Additional studies
indicate the potential for a segment-segment interaction network as a mechanism of genome
packaging and therefore determinant of reassortment17–21. However, a theoretical problem in the
field has persisted since a genome segment was first imaged in the 1970s22. The overwhelming
majority of viral RNA should be bound tightly by nucleoprotein according to prevailing
models23.
This binding, if complete, would likely impede the formation of segment-segment
interactions. However, others have shown the requirement for specific RNA features in IAV.
This discord between the requirement for and ability to form RNA features drove our
experimental design for the work described in Chapter 4. While we, and others, have reached
similar conclusions pertaining to the interaction of NP and viral RNA, further investigation
should be undertaken to complete the scaffolding our work has provided24.
To determine how genetic interaction between diverse viruses occurs during co-infection,
experiments to determine if vRNPs can be comprised of heterogeneous NP monomers from
multiple viruses should be undertaken and if NPs from different strains interact with the same
vRNA equivalently. Correspondingly, in the context of single virus and co-infection, the
interaction network of vRNAs should be determined. Reassortment between closely related IAV
occurs at high frequency and the rate of reassortment decreases, as segments are more divergent3.
Certainly, a portion of reassortment rate is determined by protein-protein component
interactions5,25–27, which allows efficient replication and overcome host restriction28,29, but the
contribution of RNA-RNA interactions must be studied further. Here, I demonstrate that the
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genetic and cellular context in which reassortment occurs couple to shape viral evolution. In
chapter 2, I demonstrated that an avian H7N3 virus is capable of acquiring segments from the
2009 pandemic that enhance pathogenesis in mice. However, many highly functional polymerase
complexes, in vitro at least, are grossly attenuated when used to infect mice4. Despite protein
compatibility, some additional function of these multifunctional proteins or underlying RNA
features rendered these viruses incapable of efficient replication. Chapter 3 addresses
competitive incorporation of the same genome segments in a different genome constellation. We
found stark differences in selection preferences of multiple segments, indicating that the genetic
context in which reassortment occurs determines the output progeny that are able to cause
subsequent infection. Surprisingly, manipulation of a single amino acid in one protein can alter
the outcome of engineered reassortment experiments, as can alteration of the constituent genetic
backbone in which these experiments take place. The constituent proteome of closely related
host species, and even tissue and cell types within a specific organism are different. Differences
in host proteins that may be utilized by the virus or more likely the presence of specific host
restriction factors and strain-specific antagonists may drive virus evolution. Specifically, the
identity of this PA amino acid (184) has previously been coupled to the ability of a different
virus strain to efficiently initiation transcription and overcome a host-adaptation block in human
cells via altered interaction with the host MCM complex30,31. Coupled with the data generated in
Chapter 3, a multifactorial model of reassortment barriers, supported by extensive data, may be
constructed in which many viral components must be congruent for efficient emergence of a new
virus. A model for the road to reassortment and barriers that must be overcome is presented in
figure 5.2. In total, the studies described herein demonstrate that both genomic RNA and
encoded proteins simultaneously contribute to the potential fitness landscape of influenza A
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viruses during co-infection and conditions amenable to reassortment.

Figure 5.2. Host and Virus-intrinsic restriction of IAV replication and
reassortment potential. Block 1: IAV must bind, enter, and fuse within a host cell.
For this to occur, the HA molecule must recognize specific sialic-acid moieties,
while evading neutralizing antibody, and fuse in the endosome at low-pH. Block 2:
Transcription and replication, including nuclear import of newly synthesized viral
proteins, are required for generation of progeny viruses. Host-specific factors are
required for these processes and inadequate host-adaptation may preclude viral
replication. Block 3: vRNP export and genome packaging are required for assembly
of nascent viral particles. Efficient interaction between vRNAs are likely required
for coordinated genome packaging and therefore may be a virus-intrinsic restriction
of reassortment and evolution. (Figure adapted from Shi, et. al.1).
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5.5

Recapitulating reassortment in a controlled manner
Prior studies of reassortment relied upon cellular co-infection and a model in which all

genome segments from parent viruses were present, yielding 28 (256) possible progeny. To
simplify this model and isolate the specific segment-based requirements and restrictions of
reassortment potential, we generated a co-transfection model to mimic reassortment in cell
culture (Figure 1.1). The resulting mixture of virus was then genotyped to determine the
preferences of reassortant segment selection in the context of two distantly related viral
backbones. We saw that for the H7N3 backbone, mostly avian origin segments were selected
with the notable exception of three segments from the
2009 pandemic H1N1 virus. We then individually generated single gene reassortant
viruses bearing seven segments of the avian virus and one segment from the pandemic virus.
These viruses were characterized for their ability to replicate in tissue culture and in the lungs of
mice. We found that substitution of three segments from the pandemic either did not alter the
virulence of the H7N3 virus in mice. Interestingly, PB2 (segment 1) resulted in morbidity in
mice surpassing that of the 2009 pandemic H1N1 itself. PB2 protein is known to be a
determinant of host range and a number of protein coding changes present in the 2009 pandemic
H1N1 PB2, but absent in the H7N3 PB2, allows increased replication in mammalian cells4.
Additionally, the inclusion of NA (segment 6) or M (segment 7) segments from the 2009
pandemic H1N1 did not attenuate the replication and pathogenesis profiles of the H7N3 virus.
Either together or individually, these segments from the 2009 pandemic H1N1 increased
transmission of previously non-transmissible viruses32,33. Therefore, it may be important to know
if North American avian H7N3 viruses that possess HA receptor binding signatures similar to
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human viruses, and bearing one of these segments, are capable of animal-to-animal
transmission34. Future studies to examine the potential for reassortment between close and
distantly related human, swine, and canine segments may be insightful given the they are all
derived from an avian origin, but replicate in distinct mammalian hosts. However, biosafety and
ethical considerations must be carefully examined prior to experimentation as a result of the
Pause on Gain-of-Function studies that occurred from 2014-2016. While, the basic knowledge of
advantageous adaptations may enhance disease surveillance, vaccine design, or accelerate
antiviral discovery, the potential for nefarious use of constructive scientific information should
be weighed with future efforts to understand what genetic features enable better replication or
transmission of IAV in humans.

5.6

Cartography of influenza A virus nucleoprotein-RNA interactions
How nucleoprotein interacts with viral RNA in cells prior to and during genome

packaging has not been addressed comprehensively at nucleotide resolution. Our studies indicate
that NP protects approximately 12 nucleotides of viral genomic RNA inside human cells, and the
profile of NP-binding to viral RNA is largely non-uniform. These findings agree with prior
estimates of the RNase protected footprint of NP and biochemical experiments demonstrating the
minimal length of RNA required for NP oligomerization in vitro35,36. The interaction of NP and
viral RNA is highly reproducible, indicating some means of phasing NP across vRNA
molecules. We propose that RNA structural elements, as well as steric constraints of the vRNP
itself, likely determine the interaction of NP and vRNA. Approximately 10% of the viral genome
is unbound at a given time and has potential to form RNA elements, both secondary and tertiary,
required for viral replication and genome packaging. NP, in either monomeric or dimeric form,
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is added co-transcriptionally as PB1 synthesizes new viral RNA and coats a majority of the
vRNA prior to nuclear export37,38. However, the addition of NP may be slower than the synthesis
and processivity of PB1, allowing local RNA structure formation. In cases where a structure has
a relatively stable fold, NP may be unable to deform the element and binds to the next adjacent
available stretch of vRNA. The non-uniform landscape of NP-vRNA interactions suggests that
these structural elements are important for the viral life cycle and corroborated by numerous
mutagenesis and bioinformatics studies of sequence conservation in potentially structured
regions39–42. An additional report of genome wide NP-vRNA association was published before
the publication of our work and corroborates our findings in the context of two different virus
strains24. A model to describe how favorable vRNA-vRNA interactions facilitate genome
packaging, while sub-optimal interactions restrict genome packaging and reassortment is
presented below (Figure 5.3) Taken together, these data suggest NP does not coat the entire IAV
genome as previously hypothesized, and the unbound regions have required functions at a
specific stage of infection.
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Figure 5.3. Model of vRNA-vRNA interactions required for IAV replication. IAV
vRNA (blue) is bound by NP (light blue) as well as the polymerase complex of PB2
(red), PB1(navy), and PA (green). NP does not bind all vRNA, leaving a portion of the
genome exposed and able to form RNA features required for formation of a transsegment interaction network. Left: Presence of congruent RNA elements enable efficient
genome packaging and potential genome reassortment. Right: Attenuation of segmentsegment interactions between non-congruent RNA elements suppresses genome
packaging and the potential for co-packaging and reassortment of these segments.
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5.7 Probing RNA structure in the viral genome
Studies performed contemporaneously, by us and others, show the potential for NP to
scaffold RNA structures, but there remains extremely limited biochemical and biophysical data
for the authentic vRNA structure in the context of vRNPs. We hypothesize that certain RNA
structures are present in NP unbound regions. However, biochemical evidence for any given
native RNA structure to form in IAV is still lacking. Future investigations utilizing dimethyl
sulfate reactivity mapping to identify what RNA bases are paired via high throughput sequencing
of total viral RNA in various forms will be efficacious in determining the most populated
structural elements43. Similarly, ongoing work in other laboratories utilizes SHAPE-seq to
determine the reactivity and solvent accessibility of unpaired RNA bases44,45. Through personal
communications, we discovered considerable correlation between our NP-unbound regions, and
regions identified as unreactive to SHAPE reagents in the context of vRNPs, indicating NP does
not bind highly structured elements. To elaborate on the function of these regions, we generated
mutant viruses predicted to alter the fold of viral RNA in an isolated sequence. Probing if, and
how, these changes in viral RNA alter RNA structure in isolation should also be undertaken.
Utilization of methods including circular dichroism (CD) or small angle X-ray scattering (SAXS)
may allow relative certainty that isolated NP-unbound regions do fold into specific structures and
manipulation of the sequence in these regions augments the stability or structural envelope of the
RNA. Together, these studies may show that NP provides an energetically and biochemically
regulated platform for RNA structure formation and interaction between segments, thereby
enabling complete multi-segment assembly and infectious particle production.
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5.8

NP-unbound regions with no known structure

In addition to large, low-NP binding regions we identified a number of short areas in the viral
genome with no known fold. Additional studies to examine the sequence requirements of these
regions should be undertaken. While we looked for NP presence along the viral RNA, it is
conceivable that the reproducible absence of NP is due to an additional host or viral factor that
binds in a sequence specific manner at these sites. While these regions we identified appear to be
of low structural complexity, a viral or host protein may compete off NP if it is present at great
enough occupancy or has a significantly greater affinity for these specific sequences.
Intriguingly, these short regions may also act as docking sites for larger structures from different
segments through which a complex web of structured and unstructured elements interact to allow
complete genome packaging.

5.9

Expanding the genomewide landscape and interaction networks for IAV
vRNA
Evidence generated in our lab and others suggests vRNA features form a multi-segment

interaction network13,46,47. Genome packaging is disrupted when mutations that are predicted to
be structurally disruptive are introduced to virus, attenuating replication, and causing the loss of
specific genome segments in total cell free virus, indicating interactions between may be
required for genome assembly. We and others have described the interactions of NP and viral
RNA in a limited set of IAV adapted to cell culture. Future studies must include a diverse array
of IAV from human, swine, and avian sources in expanded studies on the NP-vRNA interaction.
The nucleotide content of these viruses is unique and therefore each strain may have common as
well as strain-specific RNA features protruding from the vRNP core. Analysis of additional
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strain-specific elements may help elucidate how certain viruses tolerate slightly different levels
of genome packaging efficacy as well as how likely it is for viruses containing congruous protein
components to be generated following co-infection. In addition to mapping the scaffold of vRNA
adorning the ribonucleoprotein complex, efforts should be made to biochemically assess the
physical interaction network of viral RNAs with each other as well as with host RNA
particularly given the association of multiple genome segments prior to packaging20,48. Recently,
a number of proximity-dependent ligation and sequencing methods have been generated to allow
access to nucleotide resolution maps of inter-RNA interaction networks49,50. Coupled with our
knowledge of the basic NP-vRNA landscape – which enables determination of regions accessible
for cross-segment interaction – specific mapping of the authentic network of sequence elements
that contact one and other in cells and purified virus will yield the most complete understanding
of how IAV packages a complete set of eight segments with high effectiveness. As with these
studies, once a basic network map for one virus is established, it should be expanded to
determine if the contact points for both close and distant relatives of the prototype virus are
shared or dependent on genomic context.

5.10 Utilizing genome architecture data to monitor IAV evolution and guide
treatment
Mapping the genetic structure and interaction network of IAV provides insight into the
mechanisms of genome packaging and potential for reassortment. Computational models may be
developed in the future to address the likelihood of productive interaction between vRNA that
has been identified in nature and co-circulate geographically. In addition to the abundance of
knowledge on protein features required for successful interaction of viral proteins, a predictive
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model of reassortment success may be crafted to enable risk assessment of reassortant
generation, if a large enough sample of virus genomes has been assessed by methods including
PAR-CLIP and genome structure profiling. Additionally, therapeutics that target unstructured
regions of vRNA with antisense oligos have been effectively utilized in vitro to target viral RNA
for degradation, though the efficacy of these treatments in vivo has not been fully explored24,51.
Finally, vaccination with live-attenuated viruses that retain all protein components, but
reproducibly fail to replicate and package full genomes may enable generation of live-attenuated
vaccines that evoke antibody as well as cell-mediated immunity52. Taken together, our
understanding of how IAV RNA interacts between segments and if this interaction may be
successfully translated to the clinic are exciting future directions.

5.11 Understanding the multifaceted viral compatibility and host restriction
of IAV.
Herein, I have discussed three isolated but interconnected mechanisms that restrict the
evolution and host adaptation of IAV. First, the genetic backgrounds of co-infecting viruses are a
predominant driver of reassortment outcomes. Compatibility of viral proteins between strains, as
well as RNA features, are capable of either enabling efficient reassortment or killing the possible
formation of a new genome constellation. Second, the host environment in which co-infection
occurs also dictates the potential for amplification of certain progeny genotypes. If a new
reassortant combination is unable to subsequently replicate, or is attenuated relative to its parent,
it will quickly disappear from the population at large. Conversely, the combination of multiple
advantageous mutations, including escape from host immunity or enhanced utilization of a
species-specific and required host factor, in a new constellation may enhance the ability of this
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combination to spread throughout an organism, potentially leading to endemicity or pandemicity.
Finally, congruence between RNA features, scaffolded by NP at the stage of genome packaging
likely precludes the generation of multiple viruses despite compatible protein components.
Together, these layers of complexity shape the evolutionary trajectories of IAV as well as the
potential for emergence of novel genome constellations in animal and human populations. The
research presented here adds to the growing understanding of how IAV successfully replicates in
diverse hosts, with great and expanding genetic diversity, and elucidates some of the specific
molecular mechanisms by which this pathogen continues to be an annual concern for animal and
human health.
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